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Obesity and Comorbid Diseases as a Host Determinants of Staphylococcus aureus 
Colonization 
Montina B Befus 
The etiology of obesity is heterogeneous as are the cardio-metabolic 
complications, associated with it. The cardio-metabolic profile of obese individuals 
places them at risk of a range of chronic metabolic diseases including diabetes. 
Paradoxically, a subset of the population classified as obese based on established 
methods present with few metabolic abnormalities, whereas a subset classified as non-
obese present with a wide range of abnormalities. The observed heterogeneity suggests 
not only that excess adiposity is likely one of many determinant of metabolic 
complications, but also that our methods of measuring obesity might not be fully 
capturing the underlying biological mechanisms at play. The heterogeneity by which 
obesity presents itself in the general population is becoming more pertinent to the field of 
infectious diseases as findings increasingly implicate obesity in impaired host defenses 
and increased susceptibility to a range of different infectious organisms, one of which is 
Staphylococcus aureus.  
S. aureus is an opportunistic pathogen with significant infectious burdens in 
clinical, community as well as incarcerated settings. The organism also asymptomatically 
colonizes human mucosal surfaces, particularly the anterior nares. The anterior nares of 
approximately 25-30% of US adults are colonized at any given time, and prior 
colonization serves as a strong predictor of subsequent infection. Obese females have 
been consistently shown to be at elevated risk of S. aureus colonization, however, 
findings amongst obese males have been inconsistent. The mechanism by which obesity 
increases risk of colonization remain unclear, however, many cite the underlying 
metabolic/immune dysfunction that frequently accompanies obesity. Given the global 
burden of obesity and increasing evidence that it impairs host defenses, understanding 
how obesity increases host colonization with S. aureus is imperative. The overall 
objective of this dissertation was therefore to evaluate the influence of obesity and 
metabolic abnormalities on S. aureus colonization among New York State Maximum-
Security prison inmates. The objective of the dissertation was met using three aims. 
First a systematic review was conducted to assess the different definitions used to 
define persistent S. aureus colonization in community dwelling adults, as well as the 
reported prevalence estimates associated with those definitions. The study demonstrated 
that a considerable amount of variation existed in the way persistent colonization was 
defined in the extant literature. Despite the variation however, the prevalence of 
persistent S. aureus carriage remained relatively consistent after categorizing the different 
definitions into four general groups. The review also demonstrated that two groups of 
persistent carriers might exist. Therefore, differentiating strain persistence carriers from 
species persistence carriers may reconcile some of the inconsistencies with regard to 
length of strain carriage reported in the literature.  
Second, the influence of metabolic heath (a measure incorporating both body 
mass index (BMI) and metabolic abnormalities) was assessed. A significantly higher 
probability of S. aureus colonization of the anterior nares and/or oropharynx was 
observed among metabolically abnormal normal weight (BMI < 25 kg/m2) as well 
metabolically abnormal obese (BMI ≥ 30 kg/m2) females when compared to 
metabolically healthy females. No significant association was observed between the 
categories of metabolic health and the prevalence of S. aureus colonization among males. 
We did, however observe a significant decline in exclusive oropharyngeal colonization 
among obese male inmates with metabolic abnormalities.  
Lastly, factors associated with persistent S. aureus carriage were evaluated in the 
third aim. Approximately 27% of the population was persistent carriers at the species 
level and 17% were persistent carriers at the strain level. Obesity was independently 
associated with species persistent carriage but not strain persistent carriage. 
Correspondence analysis evaluating strain compositional differences between exclusive 
persistent anterior nares carriers, exclusive persistent oropharynx carriers, exclusive 
persistent carriers at both the anterior nares and oropharynx and intermittent carriers 
suggested compositional differences existed between the different groups. More 
specifically, the relative abundance of certain S. aureus strains appeared more prominent 
among exclusive nasal carriers as compared to all other carriage/mucosal site types (i.e. 
exclusive oropharynx, both nasal and oropharynx). 
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CHAPTER 1: Introduction: The Utility of Sub-phenotypes of Obesity When Evaluating its 
Effects on Infectious Outcomes 
Background and Significance 
Obesity results from storage of excess energy in the form of triglycerides in the lipid 
droplets of adipocytes, the major cell type of adipose tissue.1 To accommodate excess energy, 
adipose tissue either increases the number (hyperplasia) or the size (hypertrophy)1 of adipocytes 
in adipose tissue depots. Two main subcategories of depots are recognized: subcutaneous 
adipose tissue (SAT) located between the dermis and fascia of muscle and visceral adipose tissue 
(VAT) located within the intra- and extra peritoneal spaces of the abdomino-pelvic cavity.2 
Adipose tissue deposition displays a significant amount heterogeneity across sex, age and 
race/ethnicity.1,3 For example, males have a higher VAT/SAT ratio as compared to pre-
menopausal females.4 In addition, males have more pronounced depositions in their abdomen 
(android) as compared to the pronounced deposition in the hips and thighs (gynoid) observed in 
females.5 Further, whereas females preferentially expand adipose tissue through hyperplasia 
when deposition is in the hips and thighs, and hypertrophy when deposition is in the trunk, males 
appear to expand adipose tissue primarily through hypertrophy.1 VAT deposition compared to 
SAT, abdomen deposition compared to hips and thighs and expansion by hypertrophy compared 
to hyperplasia are all more closely associated with cardio-metabolic complications such as 
dyslipidemia, hyperglycemia, hyperinsulinemia and insulin resistance, collectively referred to as 
the metabolic syndrome.1,6 Body mass index (BMI) does not capture these differences, and 
failing to account for them masks the heterogeneity associated in the observed relationship 
between obesity and cardio-metabolic disease.7 Despite these observations, few studies 
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evaluating obesity and infections have taken these factors into account despite growing evidence 
implicating obesity in impaired host defenses and susceptibility to infections.8-11  
Another factor that needs to be taken into account when measuring the effects of obesity 
on health outcomes, specifically host defenses is the dual role of adipose tissue as both a site of 
energy storage and an endocrine organ.6 Obesity alters the endocrine functions of adipose tissue. 
For example, adipocytes secrete bioactive proteins (adipokines) that regulate metabolism, 
immunity and inflammation.12 Expansion of adipocytes can dysregulate adipokine secretion 
leading to chronic subclinical inflammation characterized by increased levels of pro-
inflammatory adipokines such as interleukin-6 and leptin, and decreased levels of anti-
inflammatory adipokines particularly adiponectin.1,6 In addition, changes in the cellular 
composition of adipose tissue due to changes in the absolute number and phenotype of the 
immune, vascular and structural cells found in adipose tissue could further impair endocrine 
function and additionally contribute to inflammation, which increases cardio-metabolic risk.6 
Given that approximately 1.9 billion adults worldwide are overweight and over 600 million are 
obese, it is imperative to elucidate the mechanism by which obesity places individuals at risk.13  
Interestingly, not all obese individuals present with increased cardio-metabolic risk 
factors; a proportion are metabolically healthy. Recognition of this has led to the development of 
a sub-phenotype of obesity referred to as metabolically healthy obese (MHO) individuals 
characterized by their relative absence of metabolic complications as compared to their 
metabolically abnormal (MAO) counterparts.14 Though, the use and utility of these sub-
phenotypes is still controversial,15,16 incorporating these sub-phenotypes has improved research 
related to metabolic diseases if for nothing else to demonstrate that heterogeneity exists in the 
subgroups (e.g. BMI category) used to define adiposity.15 These sub-phenotypes, however, have 
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yet to be implemented in research evaluating the association between obesity and host defenses 
despite accumulating evidence implicating obesity and host susceptibility to infectious 
organisms17-20 and inconsistencies in some of the findings.21-23 This dissertation aims to utilize 
obesity sub-phenotypes to evaluate their utility in infectious diseases outcomes using 
colonization by Staphylococcus aureus, an organism that has been linked to obesity,24-26 as the 
infectious disease outcome of interest.  
The sub-phenotypes of obesity often described in the literature include MHO, MAO as 
well as their normal weight counterparts, metabolically healthy normal weight (MHNW) and 
metabolically abnormal normal weight (MANW). As discussed above, the development of these 
sub-phenotypes has shed some light on the complex and heterogeneous effect of obesity on 
health.6 Whether these phenotypes represent a true subset of the population or are part of a 
continuum is still under debate.14,27 Despite this controversy, MHO individuals have been shown 
to differ in significant ways from their metabolically abnormal (MAO) counterparts including 
having lower levels of inflammation.1,14 In addition, their metabolic profile has been shown to be 
comparable to MHNW individuals and generally better than MANW individuals.27 In 
populations where markers of immune/metabolic dysfunction are prevalent, sub-typing 
individuals may provide a more granular understanding of how obesity influences outcomes 
related not only to infection but also colonization with opportunistic pathogens. More specific to 
our purposes, sub-phenotypes of obesity based on the presence or absence of morbidities 
associated with metabolic and/or immune dysfunction may provide a mechanistic insight into the 
observed association between obesity and S. aureus. Obesity has been implicated in both 
infection and colonization with S. aureus and the organism could serve as a model by which we 
can explore the effects of sub-phenotypes of obesity on infectious outcomes.  
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S. aureus is one of the most frequently isolated human pathogens in health care settings, 
and is a leading cause of both community acquired and healthcare-associated infections.28,29 
Methicillin-resistant S. aureus (MRSA) isolates were initially largely confined to hospitals and 
other health care settings. However, since the mid-1990s community-associated MRSA (CA-
MRSA) strains have emerged28 and continue to be a leading cause of uncomplicated skin and 
soft tissue infection as well as invasive disease.29 Asymptomatic colonization with S. aureus is a 
significant predictor of subsequent infection in both clinical30 and community31-33 settings, and 
also serves as a major reservoir for continued transmission.31 In fact, in clinical settings, 80% of 
S. aureus infections have been attributed to the colonizing strain, suggesting that colonization 
directly contributes to the risk of infections.30 The risk of infection is particularly pronounced 
among persistent carriers,34 defined as individuals from whom S. aureus is consistently isolated 
upon multiple sampling of the anterior nares,35-37 as compared to their intermittent carrier 
counterparts. Intermittent carriers are individuals from whom S. aureus is inconsistently or rarely 
isolated.35 Factors that predispose individuals to colonization by S. aureus include youth and 
elderly, male sex, exposure to healthcare environments as well as inconsistent findings with 
regard to medical morbidities such as human immunodeficiency virus (HIV),38,39 diabetes25,40 
and obesity24-26. More elusive are factors that differentiate persistent carriers from intermittent 
carriers, though limited evidence implicates factors related to both innate and adaptive immune 
function.41-46  
Obesity as a host determinant of S. aureus colonization warrants further investigation, 
due not only to the potential public health impact given its high and increasing prevalence world 
wide, but also its unique and sometimes inconsistent association with S. aureus infection and 
colonization.24-26 Obese individuals, have been shown to be susceptible to a variety of hospital-
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acquired infections frequently caused by S. aureus including post-operative surgical site,47,48 
catheter-related,49 bloodstream,49 wound,47 urinary tract infections and sepsis.47 In addition, in 
non-clinical settings, obese individuals are vulnerable to skin and soft tissue infections8 as well 
as bacterial complicated influenza virus infection9,10 caused by S. aureus. With regards to 
colonization, obesity as a host determinant of colonization has been reported among patients’50 
as well as non-clinically institutionalized adults.24-26 Findings among females consistently show 
an elevated prevalence/likelihood of colonization among overweight and obese females as 
compared to their normal weight counterparts.24-26 Findings among males, however, have been 
inconsistent.24-26  
Several factors contribute to the underlying theory that obesity is associated with S 
aureus colonization. First, S. aureus is a commensal that colonizes human epithelial surfaces 
without causing disease. Epithelial surfaces form the interface between the host and its exterior 
environment, and are therefore the main route of entry for microbial organisms.51 Important 
changes in epithelial tissue have been observed amongst obese individuals including alterations 
in barrier function and integrity, impaired wound healing, and increased susceptibility to 
infection.52 In addition, microbial composition of epithelial sites differ between obese and 
normal weight individuals, which has been posited to affect the pathogenicity of some of the 
residing opportunistic pathogens such as S. auerus.53,54 These observations have led some to 
hypothesize that the underlying systemic immune dysfunction observed in obesity may also 
affect local immune function at epithelial sites, including the anterior nares, leading to 
vulnerability to organisms such as S. aureus.52 The heterogeneity in the presentation of these 
characteristics among obese individuals, however, may preclude attempts to fully describe their 
influence on S. aureus colonization and explain the inconsistencies in findings among men.24-26 
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Incorporating sub-phenotypes of obesity in our measures may help differentiate obese 
individuals presenting with the biological factors that place them at risk. More importantly sub-
phenotypes may help inform prevention efforts in populations such as the incarcerated where the 
burden of both obesity and S. aureus infection and colonization are high.  
Incarcerated populations have high burden of S. aureus disease55-58 and colonization,59,60 
particularly as it relates to MRSA. The reported prevalence of MRSA colonization in 
correctional settings ranges from 0.8%-15.8% as compared to 0.8%-1.5% in non-institutionalized 
settings.25,58,60-65 Furthermore, high rates of chronic immune diseases such as HIV and hepatitis 
C virus,66 as well as chronic non-communicable diseases have been reported. In fact, age 
adjusted estimates of a nationally representative sample of incarcerated individuals report 
elevated rates of chronic metabolic/immune conditions such as hypertension, asthma, myocardial 
infarction, and diabetes among the incarcerated as compared to the general population.67,68  
A recently completed study amongst New York State maximum-security inmates funded 
by the National Institute of Allergy and Infectious Disease (5R01AI082536) confirmed the high 
rates of obesity and metabolically diseases69 as well as S. aureus colonization.65 The study also 
provides an opportunity to assess the role of sub-phenotypes of obesity on S. aureus colonization 
in a population with high burdens of both. The data comprised of over 2,800 prison inmates from 
one male and one female maximum-security prison in New York State. The study consists of 
three different cross sectional phases: inmates entering into prison, inmates during incarceration, 
and inmates being released into the community. Because a number of inmates were cultured two 
or more times during their prison stay, this study also provided a unique opportunity to evaluate 
how obesity may influence persistent carriage. Using these data, the analytical aims for this 
dissertation were therefore to assess the association between 1) obesity sub-phenotypes as 
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measured by body mass index category and the presence of metabolic/immune morbidities and S. 
aureus colonization (inclusive of both persistent and intermittent carriers) and 2) evaluate the 
association between obesity and persistent S. aureus carriage. 
Conceptual Framework 
 Two existing conceptual frameworks were used to guide the work conducted in this 
dissertation. The first framework (Appendix A1.1A) frames our understanding of how 
underlying disease could influence S. aureus colonization by illustrating how host pathology can 
alter the epithelial microbial environment through effects of the core microbiome. This 
framework is rooted in ecology and was formulated to evaluate the effects of the human core 
microbiome on disease and vice versa.70 This framework grounds our understanding of how 
obesity may influence epithelial surfaces such as the anterior nares and/or oropharynx leading to 
S. aureus colonization. The second builds on the conceptual model first described by Scrimshaw, 
Taylor and Gordon for the interaction of nutrition and infection.71 This framework describes the 
synergistic and antagonistic influence of malnutrition on infections. When the framework was 
developed malnutrition was synonymous with under nutrition, but the definition was since 
broadened by Solomons to include obesity as a form of malnutrition due to accumulating 
findings implicating obesity in infectious outcomes.72 The modified framework represented in 
(Appendix A1.1B) demonstrates the effects of obesity on the morphology and function of 
adipocytes, which in turn results in immune dysfunction characterized by chronic low-grade 
inflammation and reduced immune response of both the innate and adaptive pathways.  
Figure 1.2 modifies the above-mentioned frameworks to accommodate obesity sub-
phenotypes. In this conceptual model, excess caloric intake results in adipose tissue expansion, 
which in turn has a heterogeneous effect on both local and systemic immune/metabolic 
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function.19,20 One well-described effect is chronic low-grade inflammation that impairs both 
innate and adaptive immune response pathways.  The focus here is on host factors, specifically 
health factors that influence S. aureus colonization. Host metabolic/immune function is posited 
to influence S. aureus colonization, and is crudely captured by the presence of metabolic 
abnormalities defined in this dissertation as the presence of diabetes, hypertension and/or HIV. 
In the conceptual framework described here the sub-phenotypes should result in increasing 
prevalence of S. aureus colonization. We also posit that a more pronounced association will be 
observed between obesity and persistent S. aureus carriers as compared to intermittent carriers, 
given the underlying differences in innate and adaptive immunity observed amongst persistent 
carriers as compared to those intermittently colonized.   
Summary of Dissertation Activities 
Before embarking on the analytical aims that assessed the influence of obesity and its 
sub-phenotypes on S. aureus colonization and carriage, a systematic review of the literature was 
conducted to better understand how the definition of persistent carriage could impact observed 
estimates. Chapter 2 summarizes the results of this systematic review and also provides results of 
a meta-analysis summarizing the observed prevalence estimates for persistent carriage. The third 
chapter evaluates the association between obesity and markers of metabolic health on S. aureus 
colonization. To do so, individuals were categorized based on BMI category (normal weight, 
overweight and obese) and were then further stratified based on the presence or absence of one 
or more comorbidities (hypertension, diabetes and HIV). The association between these 
categories was then evaluated to determine if they were associated with S. aureus colonization of 
the anterior nares and or the oropharynx. Also evaluated in this chapter was the influence of the 
sub-phenotypes on site of colonization (exclusive anterior nares Vs. exclusive oropharynx Vs. 
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both anterior nares and oropharynx).  In Chapter 4, the association between obesity and 
persistent S. aureus carriage, defined as S. aureus culture positivity at each study visit, was 
assessed. The diversity of S. aureus strains as assessed by Simpson’s Index of Diversity as well 
as by multivariate techniques was also evaluated to demonstrate the utility of complimenting 
arithmetic measures of diversity with ordination techniques in an effort to more completely 
account for composition. Lastly, in chapter 5 we summarize the dissertation findings within the 
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Figure 1.1 Conceptual Frameworks Describing the Effect of Obesity Sub-phenotypes on Colonization/Infectious Outcomes  
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Figure A1.1. Established Framework Conceptualizing the Role of Obesity and Markers of Metabolic/Immune Dysfunction on 
Infection and Colonization by Opportunistic Pathogens such as Staphylococcus aureus  
   
Definitions: HIV, human immunodeficiency virus; HTN, hypertension, S. aureus, Staphylococcus aureus  
Figure A1.1A frames our understanding of how underlying disease could influence S. aureus colonization by illustrating how host 
pathology can alter the microbial environment. This framework is rooted in ecology and was formulated to evaluate the effects of the 
human core microbiome on disease. Figure A1.1B builds on the conceptual framework developed by Scrimshaw, Taylor and Gordon 




infections. At the time during which the framework was developed malnutrition was synonymous with under nutrition, but the 
definition has since broadened to include over-nutrition and obesity. The modified framework demonstrates effects of obesity on 
morphology and function of adipocytes results in immune dysfunction characterized by chronic low-grade inflammation and reduced 
immune response of both the innate and adaptive pathways.	
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CHAPTER 2: Measurement of Persistent Carriage of Staphylococcus aureus in Non-
Institutionalized Adults: A Systematic Review 
 
INTRODUCTION 
Staphylococcus aureus (S. aureus) is an important cause of both community acquired and 
healthcare-associated superficial and invasive infections.1,2 Methicillin-resistant S. aureus 
(MRSA), S. aureus isolates resistant to all available penicillin and other β-lactam antimicrobial 
drugs, have historically been confined to hospitals and other health care settings. However, since 
the mid-1990s community-associated MRSA (CA-MRSA) strains have emerged among 
populations lacking the traditional healthcare associated risk factors.2 As CA-MRSA continues to 
spread, particularly in high-risk populations such as the incarcerated3,4 and reports of 
vancomycin-intermediate or resistant organisms emerge, it is critical to elucidate the pathways 
that place individuals at risk of S. aureus infections.5,6 One such pathway, is asymptomatic 
colonization with S. aureus.  
Approximately 25-30% of healthy adults in the United States (US) are asymptomatically 
colonized with S. aureus.7,8 The most common niche for S. aureus asymptomatic colonization is 
the anterior nares, and colonization at this site is an established risk factor for S. aureus 
infections.9,10 Nasal carriage has historically been classified into three distinct patterns, 
persistent, intermittent and non-carriers.9 Broadly speaking, individuals classified as persistent 
carriers are those in whom S. aureus is consistently isolated,11 however, variations of this 
definition exist.12,13 An estimated 20% of individuals in the general population fall into this 
phenotypic category.14 Intermittent carriers are individuals in whom S. aureus is inconsistently 
isolated and non-carriers are defined as individuals who are repeatedly culture negative for S. 
	
 25
aureus. Due to similarities in carriage time and clearance rate upon artificial inoculation,15 
intermittent and non-carriers are generally described as one phenotypic category.  
Consistent culture positivity for S. aureus is not the only distinguishing factor of 
persistent carriage. Persistent carriers of S. aureus have also been shown to demonstrate less 
genotypic diversity among colonizing strains over time as compared to intermittent carriers.9,14 
For example, among persistent carriers, the colonizing strain remained identical or genetically 
similar after 8 years of follow up.13 Furthermore, artificial inoculation studies among persistent 
and non-carriers have shown that persistent carriers revert back to their original colonizing strain 
after inoculation with a mixture of S. aureus strains whereas intermittent and non-carriers do 
not.16 Secondly, the number of colony forming units (CFUs) among persistent carriers is higher 
than those found among intermittent carriers.12 Third, persistent carriage demonstrates a 
protective effect against acquisition of new S. aureus strains in health care settings as compared 
to intermittent carriers.17 Lastly, persistent colonization, as mentioned earlier, is associated with a 
higher risk of infection with S. aureus, but seems to also confer a degree of protection against a 
more severe disease course, particularly bacteremia.10,18 The determinants of which phenotypic 
category an individual demonstrates are still largely unknown.  
To date, several literature reviews have been published summarizing both host and 
bacterial factors associated with S. aureus nasal colonization, and a number were focused 
primarily on persistent carriage. Specifically, five reviews of host and bacterial factors associated 
with persistent colonization have been published,19-23 three reviews assessed factors associated 
with persistent colonization and the role it plays in infection,9,10,24 one reviewed the role of the 
host immune response as it relates to S. aureus colonization11 and one provided a comprehensive 
review of S. aureus carriage inclusive of both intermittent and persistent carriage.25 Though the 
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published literature reviews performed a comprehensive narrative review of factors associated 
with persistent colonization, none were systematically conducted. Furthermore, many alluded to 
the variability in the measurement of persistent colonization across studies; however, none 
assessed the impact of the variability on the estimated prevalence of persistent colonization. This 
review differs from previous reviews in that it is a systematic and comprehensive synthesis of 
existing literature to evaluate persistent colonization with S. aureus among non-institutionalized 
adults with a specific focus on how persistence is defined and measured across studies. The 
secondary aims were to determine whether the variability in the measurement of S. aureus 
influenced the estimated prevalence of persistent colonization and to conduct a meta-analysis of 
prevalence to calculate a summary estimate of the population prevalence of persistent carriage. 
METHODS 
This systematic review followed the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines.26  
Search Strategy and Selection Criteria 
A literature search was performed to identify peer-reviewed articles that assessed persistent 
colonization with S. aureus. Relevant articles were identified using the following databases: 
PubMed, Medline and EMBASE. In collaboration with a trained medical librarian, an automated 
search strategy was conducted using the following key words:  
1. "Staphylococcus aureus"[Mesh] OR S. aureus OR "methicillin-resistant Staphylococcus 
aureus"[Mesh] OR MRSA  
2. "Carrier State"[Mesh] OR colonisation OR colonization OR carrier OR carriage OR flora  
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3. "Prospective Studies"[Mesh] OR persistent OR "prospective studies" OR "longitudinal 
studies" OR "longitudinal study" OR "follow-up study" OR "follow up study" OR 
"retrospective studies" OR "retrospective study" OR persistence OR observational 
4. Search 1 AND search 2 as defined above 
5. Search 4 AND search 3 as defined above 
The search was limited to studies published in English in a peer-reviewed journal (conference 
presentations, abstracts and dissertations were excluded) between January 1, 2000 and November 
12, 2015. Relevant studies identified using the electronic search criteria were recorded in a 
reference manager software program (Endnote, www.endnote.com). Any duplicate entries were 
removed. 
A single reviewer (MB) screened all the titles identified using the above search strategy 
to identify titles for further review. Abstracts of articles selected based on the title review were 
subsequently screened independently by two reviewers (MB) and (SS) to determine whether the 
inclusion criteria were met. Inconsistencies between the two reviewers with regards to eligibility 
were discussed and resolved by consensus. Additional inclusion criteria considered during the 
title and abstract review included: 1) observational study conducted in community dwelling 
adults 18 years of age or older (studies conducted within health care or long term care settings 
were excluded); 2) assessed S. aureus colonization of the anterior nares longitudinally as a 
primary or secondary outcome. Studies conducted exclusively among health care 
workers/students, individuals that worked or handled livestock daily and those conducted among 
injection drug users were excluded as they represented a subset of the population that has been 
shown to have higher prevalence of S. aureus carriage.25,27 The reference lists of the included 
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articles were reviewed to identify additional peer reviewed literature that may not have been 
captured. 
Data Extraction 
All data were extracted and entered onto a standard form by one reviewer (MB). The 
primary data extracted included design (sample size, origin, and setting), participants (age, 
gender, and race), exposure(s) assessed, outcome(s), definition of persistent colonization (i.e. 
how persistent colonization was measured) and the observed prevalence of persistent 
colonization. Although the primary required outcome for included studies was longitudinal 
assessment of S. aureus colonization in the anterior nares, all outcomes assessed by the included 
articles were extracted.   
Risk of Bias in Individual Studies 
Two reviewers (MB and SS) independently assessed the risk of bias of each included 
study using a modified version of the Cochrane risk of bias tool (Appendix A2.1).28 The tool 
assessed the risk of bias on the following domains: study design, exposure assessment, outcome 
assessment and different sources of bias including but not limited to selection bias, attrition, 
misclassification or confounding. The risk of bias for each domain was assessed as low, unclear 
or high. Each reviewer then assigned each study an overall risk of the bias based on the 
performance on the different domains outlined above. Discrepancies were discussed and 
consensus achieved.  
Data Synthesis and Analysis 
Prevalence estimates for persistent S. aureus carriage were calculated by pooling the 
study specific estimates using a random effects meta-analysis that accounted for heterogeneity 
between studies. The pooled estimate excluded redundant studies that assessed different 
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exposures within the same population, studies evaluated as having a high risk of bias as well as 
twin studies.  
The binomial proportion confidence intervals for prevalence estimates were calculated by 
first performing a double arcsine transformation advocated by Barendregt et al.29 for not only 
restricting estimates between zero and one as the logit transformation accomplishes, but 
additionally producing more stable variances than the logit transformation.29 Between study 
heterogeneity was assessed using the I2 statistic,30 which measures how much of the variance 
between studies can be attributed to true differences rather than sampling error/chance. Higher 
values of I2 signify a greater degree of variation. Sub group sensitivity studies were conducted to 
determine whether a substantial change in the estimates would be observed by the general 
definition used or by geographic region. Finally publication bias of included studies was assessed 
using funnel plots and Egger’s test for asymmetry.  
Data were additionally synthesized by categorizing the definitions of persistent carriage 
used across the included studies based on commonalities between those definitions. The 
prevalence estimates of the different studies were then summarized by category to qualitatively 
assess variation in prevalence across the different definition categories. All statistical analysis 
was conducted using STATA 14.0.   
RESULTS 
 The search strategy initially yielded 5,582 records (Figure 1.1). After excluding 2,442 
duplicates, a total of 3,140 unique titles were screened for eligibility. Of the titles screened, 3,011 
were subsequently excluded, commonly because they were conducted in hospitalized patients, 
long-term care facilities or health care professionals or were primarily a pediatric population. 
Titles were also excluded if they assessed S. aureus colonization at only one time point, did not 
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assess colonization in the anterior nares, or were an intervention study. The remaining 132 
articles underwent abstract review by two reviewers and 104 were excluded primarily due to 
being conducted exclusively among healthcare professionals or individuals who regularly 
interacted with livestock. Studies were additionally excluded during the abstract review stage if 
the prevalence estimate of persistent carriage was a priori fixed based on study 
inclusion/exclusion criteria (e.g. case control study). Of the remaining 28 articles that underwent 
full article review, ten were excluded leaving a total of 18 articles that met the criteria for 
inclusion in the systematic review.  
Study Characteristics 
Eight cross sectional18,31-37 (exposure and first outcome assessment were assessed 
concurrently) and ten longitudinal12,38-46 studies were included in the study (Table 1.1). Two of 
the studies were conducted in the United States,40,43 five in the Netherlands,12,32,36,38,45 three in 
Germany,18,41,46 two in Denmark,31,33 two in Norway,42,44 two in Hong Kong,34,35 and one each in 
England39 and French Guiana.37 The sample size of the included studies ranged from 72 to 3,851 
healthy individuals. In most (73.6%) of the included studies12,31,33-35,37,39-44,46 standard methods 
for processing and confirming S. aureus through phenotypic and culture methods were used. 
Generally, samples were collected by rotating a moist or dry cotton tipped swab two to four 
times in the inner wall of both nostrils. Swabs were subsequently placed in transport medium and 
processed within three weeks of collection. Processing included incubation at 37°C for 24-48 
hours, after which colonies morphologically identified as S. aureus were cultured on blood agar 
plates and subsequently confirmed as S. aureus using various methods, the predominant one 
being an agglutination test.  Four (26%) studies18,32,38,45 provided insufficient details as to the 
laboratory methodology used to identify and confirm S. aureus colonization.   
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Measures and Prevalence of Persistent Carriage  
The definition of persistent carriage varied significantly across studies, however, 
common themes emerged that allowed for the categorization of the definitions into four different 
groups. The first major category defined persistence based on multiple assessments (> 2) of S. 
aureus carriage collected at least one week apart. Persistent carriers were S. aureus culture 
positive on all cultures.39-41 Two40,41 of these studies described culture positive results from the 
species level only, and one39 additionally examined carriage at the strain level (spa type) and 
assessed persistence of the same strain over time. When culture positivity at the species level was 
considered the prevalence of persistent carriage ranged from 18%–24%. In the study that 
assessed strain level persistence in addition to species level persistence, 18% of the total 
population was colonized with S. aureus for the duration of the study and approximately 12% 
were colonized with the same spa type.39  
The second category that emerged was a variation of the culture rule developed by 
Nouwen et al.12 Nine32,33,36,38,42-46 studies defined persistent carriage based on only two samples 
taken at least one week apart (time between samples ranged from 7-28 days). Eight32,33,38,42-46 of 
the nine studies reported persistent carriage prevalence rates ranging from 18%–27%, and one36, 
which had the smallest sample size (N=72) of all the included studies, reported a prevalence of 
33%. Of those reporting persistent carriage rates ranging from 18%–27%, four used a semi-
quantitative culture rule defined by culture positivity in both samples taken one week apart and a 
threshold of colony forming units in each sample, whereas the remaining studies conducted only 
qualitative assessments.  
The third category of definitions used was a less rigorous implementation of the culture 
rule described above, and defined persistent carriage as two samples taken several months and in 
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some cases years apart as a method of assessing persistent carriage. Of the five18,31,34,35,37 studies 
using this rule, four18,31,34,35 reported a persistent carriage rate ranging from 16%–21%, and one37 
reported a slightly higher rate of 26%.   
The final definition of persistent carriage was related to Vandenberg et al. carrier index,13 
which divided the total number of positive S. aureus cultures by the total number of cultures 
taken. Individuals with an index of ≥80% were considered persistent carriers. Only one study12 
used this definition, and the reported prevalence of persistent S. aureus carriage was 29%.  
Summary Measure of Persistent Carriage 
After taking into account redundancy due to studies assessing different factors within the 
same study population as well as high risk of bias, 11 of the 18 studies included in the systematic 
review were included in the meta-analysis. The meta-analytic pooling of the prevalence 
estimates reported by each included study resulted in a summary estimate of 22% (95% 
confidence interval, 19% – 25%) (Figure 2.2), however, a substantial amount of between-study 
heterogeneity was observed (I2 = 90.6% P < 0.01). Sensitivity analysis conducted by subgroup 
defined by region (Appendix Figure A2.1) and definition (Appendix Figure A2.2) demonstrated 
lower heterogeneity in certain groups, however prevalence estimates remained relatively 
consistent. Figure 2.3 depicts the prevalence of persistent carriage by the definition used and the 
size of the study. As is illustrated by the figure, a considerable overlap in the range of persistent 
carriage reported by definition can be observed across definitions. 
Summary of Factors Associated with Persistent Carriage 
Several demographic, behavioral and genetic factors were associated with persistent 
carriage.  As has been observed in studies evaluating S. aureus colonization at one time point, 
male sex and younger age were found to be independently associated with a higher prevalence of 
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persistent carriage.42,46 In addition to demonstrating the influence of age and sex on persistent 
carriage, Olsen et al. also reported that both smoking and serum 25-hdroxyvitamin D levels were 
associated with a lower likelihood of persistent carriage in men.42 Zanger et al. additionally 
demonstrated that hormonal contraceptive use increased the prevalence of persistent carriage.46 
Women taking contraceptives had a higher likelihood of being persistently colonized and also 
appeared to carry the same strain for longer.46 
Many of the included studies assessed the association between genetic factors previously 
shown to be associated with the immune response and persistent S. auresus carriage. For 
example, Nurjadi et al. demonstrated that genetic polymorphisms in the 5’ UTR of the DEFB1 
gene decreased mRNA expression of human β defensin 1 and 3 in experimentally wounded skin 
and correlated with persistent nasal carriage.41 Similarly, polymorphisms in the glucocorticoid 
(GC) receptor gene were associated with persistent nasal carriage45 as were single nucleotide 
polymorphisms in the IL4 and C-reactive protein gene.38 Despite positive findings with regard to 
the GC receptor, cortisol levels were not associated with persistent carriage in a small study 
conducted in the Netherlands.36 In addition, two studies assessing the heritability of persistent 
carriage failed to demonstrate an association between familial predisposition and persistent 
carriage.31,43  
Summary of Risk of Bias Assessment  
Given that the objective of this systematic review was to identify different definitions 
used to determine persistent S. aureus carriage among non-institutionalized adults and the 
resulting prevalence, the biggest threat to the validity of our summary estimate was the method 
in which persistent carriage was operationalized. Most studies had a low risk of bias with respect 
to the outcome given the studies definition (Appendix Table A2.1). However, a few 
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studies18,31,32,34,35,40,41 failed to provide one or more of the following; 1) description of time 
between sample collection and processing 2) details on enrichment 3) method of confirming S. 
aureus. Additional factors that influenced the overall risk of bias scores were uncontrolled 
confounding and inadequate description of study and source population. Factors such as previous 
antibiotic use as well as smoking, which have been shown to influence intermittent colonization, 
were not consistently accounted for, nor were adequate descriptions of the study population or 
the source population from which they were sampled included.  Despite these shortcomings, all 
the studies had well-defined exposed and comparison groups, and contributed to the scant 
literature assessing persistent carriage in non-institutionalized settings. 
DISSCUSSION 
This systematic review identified 18 studies that assessed persistent S. aureus carriage 
among non-institutionalized adults.12,18,31-46 The definitions used by each study to assess 
persistent carriage were evaluated, as were the reported prevalence estimates associated with 
those definitions. The findings demonstrated that considerable variation existed in the way 
persistent colonization was defined. The definitions fell under four general categories: culture 
positive at each point of assessment with > 2 assessments occurring a few weeks to a few months 
from one another,39-41 two positive cultures taken approximately one week apart,32,33,36,38,42-46 two 
positive cultures taken several months to a few years apart18,31,34,35,37 and lastly a carrier index of 
≥ 80% among all assessments conducted.12 The reported prevalence of persistent carriage ranged 
from 16%–33%. A summary estimate of eleven of the eighteen studies (excluding redundant 
studies and those with high risk of bias) resulted in a pooled persistent carriage prevalence of 
22% with substantial between study heterogeneity. A summary of each individual study’s 
findings as it relates to their exposure of interest and persistent carriage suggests that persistent 
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carriers harbor significantly different characteristics than intermittent carriers, regardless of how 
it is defined.  
The results of the meta-analysis estimated the pooled prevalence of persistent carriage at 
22%. It is important to note that the variability in defining persistence may have resulted in 
between-study heterogeneity above what would have been expected by chance. Our calculated 
heterogeneity was 91% and as a general rule an I2 of ≥ 75% is considered high.30,48 Therefore, 
interpretation of the pooled estimate should be approached with caution. Even after sub-setting 
by region (Figure A2.1) or the definition (Figure A2.2), of persistence used, variation in the 
prevalence of persistence was still observed, and may therefore point to true differences across 
populations. Despite the heterogeneity observed, our estimate fall within the historically 
predicted range of 20-35%.10,49 Even more striking is the consistency in the range of persistent 
carriage estimates reported across the broad categories of definitions identified. This suggests 
that identifying persistent carriers may be relatively robust to the definition used, and having at 
least two swabs may be sufficient to identify individuals at risk of carrying S. aureus for prolong 
periods of time. Future studies with multiple points of assessment should assess the performance 
of two samples taken at random time points as compared to three or more consecutive samples.    
The importance of identifying individuals who are persistently colonized with S. aureus 
and the underlying prevalence of this phenotype in the general population rests in the observation 
that persistent nasal carriage not only increases the risk of infection50 but also of transmission.35 
Several characteristics unique to persistent carriers likely contribute to these outcomes and were 
assessed by the included studies. More specifically, though inconsistencies were observed, the 
studies largely implicate factors that impair the host’s innate and/or adaptive immune response. 
For example, glucocorticoids are well known immune suppressants and are used in the treatment 
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of inflammatory as well autoimmune diseases.51 Functional polymorphisms in the glucocorticoid 
receptor genes have been shown to confer a degree of resistance to glucocorticoids leading to a 
more active innate immune response. Polymorphisms that conferred a degree of resistance to 
glucocorticoids were shown by Van den Akker et al.45 to decrease the likelihood of persistent 
carriage. Similarly, functional polymorphisms in genes coding for interleukin-4,38 which 
stimulates production of cytokines involved in S. aureus defense, and those coding for human β-
defensin-1 promoter region,41 which influences antimicrobial peptide secretion which are also 
involved in defense against S. aureus were also shown to influence persistent carriage. In 
addition serum 25-hyrdroxyvitamin D level,42 a known modulator of innate and adaptive 
immune response, was also associated with persistent carriage, however the effect was only 
observed in non-smoking men. All of these factors along with the increased S. aureus 
colonization burden and increased time associated with strain clearance observed amongst 
persistent carriers as compared to intermittent/non-carriers all suggest the involvement of factors 
that influence the host’s innate immune response in S. aureus carriage. It is important to note that 
these factors are likely multifactorial and complex as negative findings of known immune 
modulators were also observed. For example, polymorphisms in the vitamin D receptor gene, 
which have been shown to influence a host’s susceptibility to infections and host’s innate 
immunity were not associated with persistent carriage.32 The latter study, however, did not 
stratify by sex, which could have precluded their ability to detect the sex dependent association 
observed by Olsen and colleagues.42  
Other characteristics of the included studies as well as the extant literature also implicate 
factors that influence the innate and/or adaptive immune response in persistent carriage. 
Specifically, studies have shown that persistent carriage of S. aureus, frequently described at the 
	
 37
species level, can be distinguished from intermittent carriers by bacterial load, bacterial 
dispersion, and exchange rate of S. aureus clones. Persistent carriers have generally been shown 
to have a higher nasal bacterial load12,15 than intermittent carriers. For example, Van Belkum et 
al. demonstrated that persistent carriers had significantly higher mean colony-forming units per 
culture than intermittent carriers.15 Van Belkum’s observation validated an observation made by 
one of the included studies12-- that the inclusion of both quantitative and qualitative assessment 
of S. aureus improved the prediction of persistent carriage. Increased bacterial load, as was 
observed by Van Belkum et al.15 and Nouwen et al.12, likely contributes to the increased bacterial 
dispersion observed in persistent carriers as compared to intermittent carriers.52 Ho et al. further 
illustrated the increased likelihood of dispersion by persistent carriers by demonstrating that a 
substantial amount of the hand contamination with S. aureus observed among food handlers was 
similar/identical to strains cultured from persistent carriers.35 
The last characteristic of persistent carriers demonstrated by studies included in this 
analysis as well as the extant literature is related to the exchange rate of S. aureus clones upon 
repeated culture. Van Belkum et al. reported a significantly lower exchange rate among 
persistent as compared to intermittent carriers.15 In fact, after de-colonization, persistent carriers 
reverted back to their endogenous strain 50% of the time suggesting a symbiotic relationship 
between host and bacteria, and carried the strain for >154 days. Miller et al. observed similar 
findings, reporting S. aureus loss rates of 4-6 months (120-180 days) among persistent carriers as 
compared to two months among intermittent carriers.39 The observations of Van Belkum et al.15 
as well as Miller et al.12, however, were not supported by a three year longitudinal study 
conducted by Muthukrishnan et al.40 The latter assessed whether a strain change occurred within 
the study period rather than an average of how long a strain was carried. Given the duration of 
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the study (3 years), it is likely that persistent carriers changed strain types several times, however 
the length of time during which they carried each colonizing strain may be the salient question 
rather than whether change occurred.   
Another salient question that needs to be addressed is whether there is a need to 
distinguish “truly persistent” from “consistent carriers” as defined by Miller et al.39 In one of the 
most extensive studies assessing persistent carriage Miller and colleagues argue that a “truly 
persistent” carriage phenotype does not exist. The authors suggest that the existence of this 
phenotype would be characterized by a loss rate of S. aureus reducing to zero some time after 
24-30 months of follow up. Because loss decreased linearly throughout the study, the authors 
hypothesized that all of those being followed would eventually lose carriage. If the purpose of 
assessing persistence is to identify individuals at risk of infection and those at increased 
likelihood of transmitting the bacteria then the interest in a gradient of risk may be of little 
consequence.  If the purpose, however, is to increase the precision of how persistence is 
measured, then understanding what proportion of individuals can be truly described as persistent 
carriers per Miller et al.39 may be of some value. Demonstrating whether these individuals harbor 
significantly different characteristics from individuals they defined as consistent carrier would 
likely require large sample sizes and long follow up periods. Such studies are sill warranted as 
they may strengthen the evidence of an association between currently recognized characteristics 
and clarify some of the controversial findings that may have resulted from misclassification of 
phenotypes.   
Another area in which precision in the measurement of persistent colonization might be 
relevant is in the assessment of the role of the nasal microbiome on S. aureus carriage. None of 
the included studies assessed the role of the nasal microbiome on S. aureus persistence, and to 
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date no study has assessed longitudinal carriage of S. aureus within the context of the entire 
nasal ecology. Observations reported in a recent study conducted by Lu et al. suggested that the 
nasal taxa determined S. aureus colonization (assessed at one time point) by influencing both its 
presence as well as its absolute abundance.53 Authors described seven major “community state 
types”, each characterized by a “uniquely high prevalence and proportional abundance of 
specific nasal bacteria”53. Community state type 1 was characterized by the high prevalence and 
relative abundance of S. aureus. Authors also demonstrate a negative correlation between 
Corynebacterium and Propionibacterium abundance and S. aureus carriage, a finding that 
mirrors others54,55 in the literature assessing the microbiome and S. aureus carriage. A degree of 
granularity could be introduced into these assessments should S. aureus carriage phenotypes be 
taken into account. 
This systematic review has several limitations. First, only 18 studies met the established 
criteria for study inclusion. The low yield is likely due to the difficulty in assessing S. aureus 
persistent carriage in non-institutionalized settings. Persistent carriage requires a longitudinal 
assessment of carriage; therefore there is a higher risk of bias from differential loss to follow up 
especially when conducted in non-controlled general population settings. The low yield could 
also be due to some articles being overlooked during the literature search because the 
assessments of persistent carriage were not indicated in the title or abstract. To mitigate this 
potential limitation, a broad search was conducted in which 3,144 unique titles were screened as 
well as 132 abstracts and references of included studies. Furthermore, a significant amount of 
persistent carriage studies were conducted amongst individuals with a high risk of exposure such 
as health care workers, livestock farmers, and patients. These populations were omitted in an 
attempt to limit misclassification of persistent carriage due to frequent exposure as compared to 
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persistent carriage due to the biological description of the phenotype. Persistent carriage rates in 
these settings would be artificially increased and thereby artificially increase the study specific 
prevalence of persistence as well as the resulting summary prevalence. Second, the heterogeneity 
in the summary estimates was high suggesting a significant amount of heterogeneity across 
studies. Inconsistencies in how study variables were collected precluded the implementation of a 
meta-regression analysis based on study definition, as did the small number of unique study 
populations represented in each definition. The prevalence by persistent carriage across 
definitions, however, suggests that despite the high heterogeneity, persistent carriage rates were 
relatively consistent. Finally, as in all systematic reviews and meta-analysis there is a risk of 
publication bias, however the funnel plot and the accompanying egger statistic provided little 
evidence for publication bias (Appendix Figure A2.3).   
Conclusion 
In conclusion, varying methods have been implemented to define and identify persistent 
carriage among non-institutionalized adults. Despite the definitional differences implemented, 
the prevalence of persistent carriage reported was relatively comparable suggesting that 
measuring persistent carriage prevalence may be robust to the different methods currently being 
implemented. In addition, factors that influence the host’s innate and/or adaptive immunity were 
heavily implicated in S. aureus persistent carriage. Known immune modulators, such as obesity, 




Tables and Figures 
Figure 2.1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Flow Chart Illustrating the 
Selection Process of Articles Included in the Systematic Review 
  
Flow diagram of search strategy and selection process for systematic review of studies that assessed persistent Staphylococcus aureus 
carriage among non-institutionalized adults  
3,140 Citations Identified Through Database Search 
  •Pubmed 1,526 titles  
  •Medline 1,596 titles 
  •Embase 2,460  
3 Citations Identified Through Included 
Titles Reference Search 
3,140 Unique Titles Screened 
132 Articles with Abstracts Assessed for Eligibility 
28 Full Length Articles Assessed for Eligibility 
18 Articles Included in the Final Systematic Review 
3,011 Articles Excluded 
107 Articles Excluded 




















US NR 109 •All nasal cultures tested S. aureus 
positive for the duration of the study 
•median of 4 nasal samples (range 2-18) 
18 •23.8% 




603 •Four consecutive positive nasal swabs 
(mean of 75 days first and last swab) 
4 •20% 




1,123 •Consistent Carriage Species Level= 
Individuals consistently colonized with 
S. aureus for duration of the study (~3 
years)  
•Consistent Carriage Spa type Level= 
Individuals colonized with the same S. 
aureus spa-type for long time periods 
(~3 years) 
14 • Species Level 
17.6% 
 
• Spa type Level 
12.6% 
General Definition: Two Positive Cultures taken ~ 7-28 days Apart 




3,851 •Two positive quantitative nasal swab 
cultures taken one-week apart with at 
least 8 colony-forming units of S. aureus 
per culture 
2 • 18% 





2,929 •Two positive nasal swabs taken one 
week apart 
2 19.2% 




3,851 •Two positive quantitative nasal swab 
cultures taken one-week apart with at 
least 8 colony-forming units of S. aureus 
per culture 
2 •18% 
Fode P. et al.,  
2011 
Denmark NR 169 •Two successive positive nasal swabs 
taken one week apart 
2 •20% 





398 •Two positive cultures with an average 



















2,997 •Two positive S. aureus cultures taken 
within a few weeks of each other 
(median 28 days) 




Manenschijn L. et 
al., 
2012 








2,780 •Two positive S. aureus cultures taken 
within a few weeks of each other 
2 •34% among men
•21% among 
women 




1,180 •Two positive nasal swabs taken one 
week apart 
4 •22% 
General Definition: Two Positive Cultures Taken a Few Months to Years Apart 
Hofltreter S. et al.,  
2006 
Germany NR 123 •Two S. aureus positive nose swabs 
(swabs were drawn at maximum 3 
months apart) 
2 •18% 
Ruimy R. et al.,  
2010 
French Guiana 2006, 
2008  
154 •Persistent carriers were culture positive 
S. aureus in both the 2006 and 2008 
assessment 
2 •26% 




617 twin pairs  
 
•S. aureus colonization at both sampling 
points taken one year apart 
2 • 21%  
 
Ho J. et al.,  
2015 
Hong Kong 2002, 
2003, 
2011 
499 •S. aureus positive in both the 2002 and 
2003 assessments 
2 •16% 
Ho J. et al., 
2015 
Hong Kong NR 540 •Individuals colonized with S. aureus 
spa type at both time points assessed 
2 •16% 
General Definition: Carrier Index 




• 51 for derivation 
cohort 
 
•106 for validation 
cohort 
•Persistent S. aureus carriage 
characterized as 9-10/10 cultures 
positive for S. aureus 
12 •29% in the 
derivation cohort 
 
•30% in the 
validation cohort 
Abbreviations: US, United States;  









Figure 2.2. Meta-Analysis of the Prevalence of Persistent Carriage Among Studies Conducted in Non-Institutionalized Adults 
from 2000 to 2015 
  
Abbreviations: ES, Prevalence Estimate, CI, Confidence Interval 
I2 refers to the heterogeneity across studies with heterogeneity of ≥ 0.75 reflective of significant between study heterogeneity 




Figure 2.3. Prevalence of Persistent Staphylococcus aureus Carriage Reported by Studies Conducted from 2000 to 2015 
According to the Definition of Persistence Used 
	 	
Figure 1. The bubble sizes shown are proportional to the number of participants enrolled in the study at baseline.  
Definition 1: S. aureus culture positive for each sample taken a few weeks-months apart;  
Definition 2: Two positive S. aureus cultures taken approximately one week apart;  
Definition 3: Two positive S. aureus cultures taken several months to a few years apart;  
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Table A2.1 Risk of Bias Assessment Tool 
Domain  Description Review 
Author’s 
Judgment 
Study Design ‐ Key elements of study design, namely type of design, setting, location, 
time frame and sample population (study population i.e. 
exposed/unexposed, cases/control do not pose a cause for concern) are 
appropriate for the study question 
‐ Eligibility criteria for study is appropriate  
‐ Biological specimen collected, if relevant are collected, stored and 
processed in manner that pose no threat to validity of the resulting data 
(amount of sample, nature of collecting procedures, time between sample 






‐ Exposure should be clearly defined  
‐ If molecular exposure is being assessed, the type of assay used, detection 







- Outcome is clearly defined  
- Time frame between samples should be explicitly stated 
- In case of multi-site swabbing, it should be stated whether swabs were 






- Loss to follow up, confounding, effect measure modification, missing 






Risk of Bias  Interpretation Within a Study 
Low risk of bias Plausible bias that unlikely to 
seriously alter the results 
Low risk of bias for all key 
domains 
Unclear risk of bias Plausible bias that raises doubt about 
the results  
Unclear risk of bias for one or 
more key domains 
High risk of bias Plausible bias that seriously weakens 
confidence in results 
High risk of bias for one or more 
key domains  




Table A2.2 Risk of Bias Assessment for Articles Included in the Systematic Review  
Article Overall Risk of 
Bias 
Andersen et al. 2012 High risk  
Claassen et al.  2005 Unclear risk  
Emonts et al.  2008 Low risk 
Fode et al.  2011 Low risk 
Ho et al.  2015  High risk 
Ho et al.  2015 High risk 
Holtfreter et al.  2006 High risk 
Manenschijn et al.  2012 Unclear risk 
Miller et al.  2014 Low risk 
Muthukrishnan et al.  
2013 
Unclear risk 
Nouwen et al.  2004 Unclear risk  
Nurjadi et al.  2013 Unclear risk 
Olsen et al.  2012 Low risk 
Roghmann et al.  2011 Low risk 
Ruimy et al.  2010 Low risk 
Sangvik et al.  2011 Low risk 
Van den Akker et al.  
2006 
Unclear risk  




Figure A2.1 Meta-analysis of the Prevalence of Persistent Carriage Stratified by Region of Assessment 
	  
Group 1: studies conducted in the United States, England, Denmark, Norway & French Guiana; Group 2: Studies conducted in Germany; 
Group 3: Studies conducted in the Netherlands 
Abbreviations: ES, Prevalence Estimate, CI, Confidence Interval 
I2 refers to the heterogeneity across studies with a heterogeneity of ≥ 0.75 reflective of significant between study heterogeneity 




Appendix A2.2 Meta-analysis of the Prevalence of Persistent Carriage Stratified by Definition of Persistence Used 
  
Abbreviations: ES, Prevalence Estimate, CI, Confidence Interval 
Definition 1: S. aureus culture positive for each sample taken a few weeks-months apart;  
Definition 2: Two positive S. aureus cultures taken approximately one week apart;  
Definition 3: Two positive S. aureus cultures taken several months to a few years apart;  
Definition 4: A carrier index of ≥ 80% among all S. aureus swabs collected.  
I2 refers to the heterogeneity across studies with a heterogeneity of ≥ 0.75 reflective of significant between study heterogeneity 




Appendix A2.3 Funnel Plots of Studies Included in the Meta-Analyses of Persistent Staphylococcus aureus Carriage 2000-2015 
 
Funnel plots are graphical representations of the logarithm of each study's prevalence estimate versus the standard error of the logarithm 
of each study's prevalence estimate. The dotted lines are pseudo 95% confidence intervals.
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CHAPTER 3: The Association between Obesity and Comorbid Conditions and 
Intermittent Staphylococcus aureus Colonization 
 
INTRODUCTION 
Obesity, characterized as a state of excess adipose tissue (fat), is a recognized chronic 
condition that has reached epidemic levels.1,2 Approximately 1.9 billion adults worldwide are 
overweight and over 600 million are obese.3 In the United States, over 30% of adults 20 years of 
age or older are obese, and rates are higher among Hispanics (42%) and non-Hispanic Blacks 
(48%).4 It is now well established that obesity increases the risk of metabolic diseases such as 
type 2 diabetes, hypertension and ischemic heart disease5. However, evidence now also 
implicates obesity in impaired host defenses resulting in an increased susceptibility to clinical 
and community acquired infections.6,7 One organism that has been linked to obesity is 
Staphylococcus aureus,8-10 the most frequently isolated human pathogen in health care settings, 
and a leading cause of both community acquired and healthcare-associated infections.11,12 
S. aureus is not only an opportunistic human pathogen, but also a transient and 
sometimes persistent component of the resident flora of the human anterior nares, the organism’s 
ecological niche.  Approximately 25-30% of US adults are colonized at this site at any given 
time,9,13 and prior colonization serves as a strong predictor of subsequent infection14 and 
transmission.15 Identifying factors that predispose individuals to colonization has the potential to 
contribute substantially to the reduction of S. aureus disease burden in both healthcare and 
community settings, however, host determinants of colonization, and more particularly persistent 
colonization, are still largely unknown.16 Factors that have been shown to influence S. aureus 
colonization include age, smoking, 25-hydroxyvitamin D levels,17,18 female hormonal 
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contraceptive use,19 and genetic polymorphisms in genes associated with immune function.20-22 
Unfortunately, many of the findings have yet to be reproduced, and in the case of 25-
hydroxyvitamin D levels, supplementation did not significantly reduce S. aureus carriage.23 One 
host factor that, however, appears to be consistently associated with S. aureus colonization is 
obesity.   
Obesity as a host determinant of S. aureus colonization has been reported among 
patients,24 non-institutionalized adults8,9 and maximum-security inmates.10 Though findings 
among females in non-clinical settings consistently show a higher prevalence among the obese,8-
10 results among males have been inconsistent, and only one study9 demonstrated a significantly 
elevated prevalence among obese males. Mechanisms that might mediate the observed 
association between obesity and S. aureus colonization, particularly among females, have yet to 
be elucidated, however, the metabolic abnormalities and accompanying immune dysfunction 
frequently observed in obesity has been posited.8,25 Interestingly, elevated glucose 
concentrations, an established marker of metabolic dysfunction,26,27 is associated with S. aureus 
colonization,9,28 suggesting that altered glucose metabolism could mediate the association 
between obesity and S. aureus. Unfortunately, the independent effects of other markers of 
metabolic dysfunction that frequently cluster with obesity including hypertension, low high-
density lipoprotein-cholesterol (HDL-C) levels and elevated level of triglyceride have yet to be 
evaluated. Obese individuals that present with this clustering of metabolic complications are 
generally defined as having metabolic syndrome29 or having metabolically abnormal obesity 
(MAO). There are, however, 20-30% of obese individuals that are metabolically healthy 
(MHO).30 Conversely, a clustering of metabolic complications in the absence of obesity, 
frequently referred to as metabolically abnormal normal weight (MANW) 31,32 has also been 
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observed. The impact of these phenotypic categories of obesity and metabolic health on 
infectious disease outcomes have yet to be evaluated despite increasing evidence linking obesity 
with infectious outcomes33,34 and calls to phenotype obesity.35  
In an attempt to elucidate the association between obesity and S. aureus colonization, we 
assess here the influence of obesity and comorbidities associated with metabolic and/or immune 
dysfunction on S. aureus colonization. We hypothesize that obese individuals with metabolic 
abnormalities will have a higher prevalence of S. aureus carriage than obese individuals that are 
metabolically healthy.  
 
METHODS 
Setting and Sample  
Data from an NIH-funded study (5R01AI082536) of S. aureus prevalence and risk 
factors in two NYS maximum-security prisons, Bedford Hills Correctional Facility (Female 
prison) and Sing Sing Correctional Facility (male prison), were used. Study data were collected 
in three distinct phases: (1) when inmates entered the facility (intake), (2) at any time point 
during incarceration (cross-sectional), (3) when inmates were being released back into the 
general population (discharge). Both participating facilities are located in Westchester county 
New York (NYS).  
Participant Recruitment  
Participant recruitment began in January 2009 and ended in February 2014. Inmate 
participation at both facilities was voluntary and compensation was not provided. Eligible 
participants were inmates ages 16 years or older capable of providing informed consent. The 
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Institutional Review Boards of Columbia University Medical Center (CUMC) and the New York 
State Department of Corrections and Community Supervision (DOCCS) approved the study.  
To recruit participants for intake, inmates entering either the female or the male prisons 
were invited to participate in the study when they first entered the facility and while being 
processed. One of five trained research associates from CUMC invited the inmates to speak with 
them in a private room. At this time, inmates were provided with a brief description of the study 
and informed consent was solicited along with Health Insurance and Portability and 
Accountability Act (HIPAA) release. Recruitment for the cross-sectional phase varied by prison 
facility. In the female prison, inmates were called to the facility medical center and invited to 
participate. To recruit participants in the male prison trained research associates visited 
classrooms in the school, vocational training, and counseling buildings, and asked inmates if they 
were interested in participating in the study. At both facilities, interested inmates were 
subsequently invited to speak with a trained research associate from CUMC in a private room 
and were enrolled in the cross-sectional phase if informed consent was provided. Recruitment for 
the discharge phase was similar for both facilities; inmates scheduled for release back into the 
community were called to the facility medical center and invited to speak privately with a trained 
research associate.  
Data Collection and Extraction 
Trained research associates used a structured questionnaire to interview participants and 
collect demographic, behavioral and medical history information. During the interview, 
participants were cultured at the anterior nares and oropharynx, and culture swabs were later 
processed to assess asymptomatic colonization with S. aureus. In addition, research associates 
extracted data from the medical charts of inmates focusing on the NYS DOCCS Health Services 
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System problem list and the provider’s progress notes. Medical conditions were included in an 
inmate’s Health Services System problem list during the intake processing and/or anytime during 
incarceration. Upon entry into DOCCS, each inmate underwent a medical screening process that 
includes a detailed medical history, blood tests, dental and chest X-ray. In addition, every inmate 
is offered a human immunodeficiency virus (HIV) test at prison entry, and those at risk for 
hepatitis C virus (HCV) based on medical and drug history screenings were tested for the 
condition. Medical conditions of note at screening were included in the Health Services System 
problem list, or were included in the progress notes of an inmate’s medical chart.  In addition, 
any medical condition identified during incarceration was included in the problem list and /or the 
progress notes along with any medical procedures and/or laboratory tests conducted while 
incarcerated.  
Assessment of Multiple Comorbidities (Exposure Assessment) 
Body mass index (BMI) category was the index condition under study, and was assessed 
by first calculating the BMI of each inmate based on self-reported height and weight using the 
following equation 
	 	 	703 .  Inmates were then categorized as normal weight, 
overweight or obese based on having a BMI of <25 kg/m2, 25-29.9 kg/m2 or ≥30 kg/m2, 
respectively. After BMI category was defined, metabolically abnormal health status was then 
established for each participant. Metabolically abnormal health was defined as being diagnosed 
with one or more of the following conditions: diabetes, hypertension and/or HIV. These 
conditions were chosen based on established literature suggesting: 1) natural disease course 
affects and/or is affected by either innate and/or adaptive immune function and/or response 2) are 
also independently associated with obesity and/or fat distribution. Hypertension and diabetes are 
established markers of abnormal metabolic status.32 We include HIV in this index due to its high 
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prevalence among incarcerated population, established affect on immune function and its 
association with the redistribution of fat both independently and as a result anti-retroviral 
therapy.36,37 An inmate whose medical chart problem list or progress notes contained the 
diagnosis of HIV, diabetes and/or hypertension was defined as having the condition. The 
following categories were then created as defined in Table 3.1 based on BMI category and 
unhealthy metabolic health; metabolically healthy normal weight, metabolically abnormal 
normal weight, metabolically healthy overweight, metabolically abnormal overweight, 
metabolically healthy obese, metabolically abnormal obese. Similar methods have been 
previously used to measure metabolic health.38 
Characterization of S. aureus (Outcome Assessment) 
S. aureus characterization was carried out as previously described.39 Swab samples 
obtained from the anterior nares and oropharynx of participants were incubated overnight in 6% 
sodium chloride-supplemented tryptic soy broth (Becton Dickinson) at 35°C. This particular 
broth was used to enrich S. aureus selection. Aliquots of the broth were then plated onto 
mannitol salt agar (Becton Dickinson) and incubated for 48 hours at 37°C. Individual colonies on 
the salt agar plates that were morphologically identified as S. aureus were streaked onto sheep 
blood agar plates and subsequently confirmed as S. aureus using the coagulase and protein A 
detection kit (Murex Staphaurex, Lenexa, KA). Confirmed isolates were then characterized by 
spa typing and compared using Ridom Staph Type software (Ridom GmBH). In order to 
determine the clonal relatedness of the different S. aureus strains identified in the population, spa 





Self-reported age, sex, race (non-Hispanic white, non-Hispanic Black, Hispanic and 
other), education (less then high school, high school grad, some college/college grad), antibiotic 
use in the past six months (yes/no), Current smoking (yes/no), number of showers per week, 
other underlying chronic conditions (liver disease, kidney disease, asthma) and history of drug 
use (marijuana use in the past 6 months, heroin use ever, crack/cocaine use ever) were assessed 
as potential confounding variables. Also assessed were systemic and/or topical antibiotic use in 
the past six months. These characteristics were assessed as potential confounding variables based 
on literature indicating an association with both the exposure and the outcome. For example, 
increasing age, non-Hispanic black and Hispanic race, education as well as smoking are 
associated with increased prevalence of diabetes and hypertension as well as their co-occurrence, 
and are additionally associated with S. aureus colonization.5,41 14  
Statistical Analysis 
Means and standard errors were calculated for continuous variables and frequencies and 
percentages were calculated for categorical variables. Bivariate analyses were conducted using 
chi-squared tests or t-tests as appropriate. Multivariable analysis using log-binomial regression 
was then conducted to assess the association between the exposure, metabolic health and the 
likelihood of being colonized with S. aureus. Age, race, education and smoking status were 
included in the model as covariates based on a priori knowledge of their association with 
metabolic health status and S. aureus colonization. In addition covariates that were associated 
with both the exposure and outcome with a 10% level of significance and additionally changed 
the beta estimate for metabolic health status by 10% or more were retained in the final model. 
Both statistical and biological interaction by gender was assessed. To assess statistical 
interaction, cross product terms between comorbidity status and gender were included in the log-
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binomial model, and a likelihood ratio test based on the -2 log-likelihood estimates of the full 
(with the interaction term) and reduced (without the interaction term) models were assessed. To 
assess biological interaction, the relative excess risk of regression as described by Rothman42 and 
95% confidence intervals as described Hosmer and Lemeshow43 were calculated. Final models 
were stratified by gender based on extant literature of the variation across gender with regards to 
metabolic outcomes associated with obesity.5,44 
To further elucidate the association between obesity and S. aureus colonization, we used 
multivariable multinomial logistic regression to evaluate whether metabolic health status 
influenced site of colonization among those colonized. Potential confounding factors associated 
with metabolic health status and the multinomial outcome (anterior nares, oropharynx, both sites) 
with a 10% level of significance, and additionally changed the beta estimates for metabolic 
health status by 10% or more were included in the final model.  
Several sensitivity analyses were conducted to evaluate how robust our results were to 
misclassification and assumptions about/treatment of missing data. First we conducted a 
quantitative bias analysis to examine how robust the findings were to misclassification of self-
reported height weight and metabolic health. We hypothesized that the results obtained would 
not change appreciably after accounting for misclassification of BMI category and comorbidity. 
Based on the literature we assumed perfect specificity45 and any misclassification resulted from 
under reporting of weight, over reporting of height or under diagnosis of medical comorbidities. 
We also assumed that misclassification occurred only between adjacent cells. Monte Carlo 
simulation studies with a uniform distribution and bootstrapping methods were then conducted. 
To do so 10% of the population was randomly selected and their BMI category changed to 
reflect what was presumed to be the true BMI category. Separately, 10% of the population was 
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also randomly selected and their comorbidity category changed to reflect what was presumably 
their hypothetically true category.  Figure 3.1 illustrates the different steps used to obtain the 
estimates. The multivariable log-binomial regression model was then fitted to reflect the changes 
and the process repeated 1000 times. A summary measure reflecting the median estimate and 
standard error across all simulations was then obtained. The second sensitivity study evaluated 
our comorbidity construct for misclassification due to the inclusion of HIV.37 Though HIV is 
associated with metabolic and immune dysfunction46 not all individuals present with these 
symptoms. Furthermore, individuals in whom the only comorbidity is HIV may have risk factors 
that place them at elevated risk of colonization.47 To assess the robustness of our construct, we 
excluded HIV from our measure, but included it as a covariate in our multivariable model. We 
hypothesized that our inferences would remain the same, but our standard errors would increase.  
Additionally, multiple imputation analysis was conducted to determine whether estimates 
changed substantially from the complete case analysis that was conducted as compared to 
available case and full data with all observations included. Lastly we conducted a sensitivity 
study assessing the influence of metabolic abnormalities within levels of BMI category, and 
another study assessing the influence of BMI category within levels of metabolic health. All 
statistical analyses were conducted using SAS, version 9.3 (SAS Institute, Inc., Cary, North 
Carolina) and STATA version 14.0.  
RESULTS 
Participation rates at both facilities were high for each phase of the study ranging from 
81-87% for the female prison and 80-94% for the male prison. Characteristics of the total sample 
stratified by gender and S. aureus colonization status are presented in Table 3.2. The mean age of 
the 1,357 female and 1,472 male participants were 37 ± 11 and 37 ± 10, respectively. 
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Approximately 70% of all female and 65% of all male participants had a high school diploma or 
GED. Forty-three percent of all female participants were non-Hispanic black, 33% were non-
Hispanic white, 16% were Hispanic and approximately 7% were of other or mixed race. Among 
male participants, 56% were non-Hispanic black, 10% were non-Hispanic white, 29% were 
Hispanic and 5% were of other or mixed race.  
The mean BMI for female participants was 29.5 kg/m2 ± 6.7. Approximately 41% of all 
female inmates were considered obese (BMI ≥ 30kg/m2), and 20% were severely obese (BMI ≥ 
35kg/m2) (Table 3.3). The prevalence of obesity was highest among non-Hispanic black women 
(49%). Twenty seven percent of all female inmates reported one or more metabolic 
abnormalities. The prevalence of metabolic abnormalities among obese, overweight and normal 
weight women was 37%, 23% and 17%, respectively.  
The mean BMI among male participants was 27.9 kg/m2 ± 4.5 (Table 3.3). The 
prevalence of obesity (BMI ≥ 30kg/m2) was approximately 26% and only 6% were severely 
obese (BMI ≥ 35kg/m2 ). Twenty-seven percent of non-Hispanic male participants were obese. 
Twenty percent of all male participants reported at least one marker of metabolic abnormalities. 
When assessed across levels of BMI category, 32% of obese, 17% of overweight and 13% of 
normal weight males reported at least one marker of metabolic abnormality.    
The prevalence of S. aureus colonization was 45% among all female participants, and 
was lowest (39.4%) among normal weight female participants with no recorded markers of 
metabolically abnormal health (Table 3.3). S. aureus prevalence rates increased to approximately 
51% among normal weight female participants with at least one marker of metabolic 
abnormality. Prevalence was 46% and 41% among overweight female participants free of and 
those with markers of metabolically abnormal health, respectively. S. aureus colonization rates 
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were approximately 46% and 50% among obese female participants with and without markers of 
metabolically abnormal health status, respectively. Prevalence rates did not significantly differ 
by metabolic health status in unadjusted analysis (P=0.15) Table3.3. Colonization rates were 
47% among normal weight men with no markers of metabolic abnormality, 42% among normal 
weight men with one or more metabolic abnormalities, 51% among overweight men with no 
metabolic abnormalities, 41% among overweight men with metabolic abnormalities, 52% among 
obese men with no metabolic abnormalities and 49% among obese men with metabolic 
abnormalities.  
In the multivariable analysis (Table 3.4), the prevalence of S. aureus colonization among 
normal weight females with metabolic abnormalities was significantly higher than those of 
normal weight female participants with no metabolic abnormalities (PR=1.34, 95% confidence 
interval (CI) 1.01, 1.77). The multivariable model controlled for the effects of age, race, 
education, smoking, study phase, marijuana use in the past six months, heroin use ever, injection 
drug use, hepatitis C virus infection, systemic antibiotic use and topical antibiotic use. Obese 
female participants with metabolic abnormalities also had a higher likelihood of S. aureus 
colonization (PR=1.28, 95%CI 1.05-1.57) after controlling for the relevant covariates mentioned 
above. No statistically significant association was observed between metabolic health status and 
S. aureus colonization among male participants after controlling for covariates.  
Results of the sensitivity studies (Appendix Table A3.1) demonstrated that our findings 
were somewhat robust for obese females with metabolic abnormalities but not for normal weight 
females with metabolic abnormalities with regard to misclassification of BMI category and 
metabolic health status. Furthermore, the effect estimates increased and remained significant 
when HIV was removed from the comorbidity estimate and controlled for in the model 
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(Appendix Table A3.2), and remained relatively unchanged between the complete, available and 
multiply imputed models assessing the impact of missing data (Appendix Figure A3.1). When 
we restricted our assessments to within metabolic health status (Appendix A3.5) or BMI 
category (Appendix A3.6) we observed no differences in the prevalence of S. aureus 
colonization across the different BMI categories, but observed an effect of metabolic health 
across levels of BMI. More specifically, a significant difference in the prevalence of S. aureus 
was observed when MANW was compared to MHNW (PR=2.15 95%CI 1.11, 4.18), but not 
when MAO was compared to MHO (PR=1.16 95%CI 0.79,1.72). Inferences in the results of the 
sensitivity studies in males (Appendix Table A3.1, Table A3.2, Figure A3.2, Table A3.5, Table 
A3.6) did not change from what was observed in our final model.  
Table 3.5. provides the results of S. aureus colonization by site. Among the 612 female 
participants colonized with S. aureus 14% were colonized in the nares only, 17% were colonized 
in the oropharynx only and 13% were colonized at both sites (Table 3.3). Metabolic 
abnormalities were not significantly associated with site of colonization among female 
participants; however, exclusive nares colonization was 18%, 13% and 21% among normal 
weight, overweight, and obese female participants with metabolic abnormalities, respectively. 
Among the 722 males colonized with S. aureus, 12%, 23% and 14% were colonized exclusively 
in the anterior nares, exclusively in the oropharynx and both sites, respectively. Site of 
colonization was significantly associated with metabolic abnormalities among male participants 
in bivariate analysis (P< 0.01). In multivariable multinomial logistic regression analysis, obese 
male with metabolic abnormalities were significantly more likely (OR=2.40, 95%CI 1.13, 5.09) 
to be colonized exclusively in the anterior nares as compared to exclusive oropharynx 
colonization than normal weight males with no comorbidities after controlling for age, race, drug 
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use, and hepatitis C infection. No statistically significant difference by metabolic health status 
was observed for female participants with regards to site of colonization.  
DISCUSSION 
We demonstrated an effect of metabolic abnormalities on S. aureus colonization of the 
anterior nares and/or oropharynx among female maximum-security inmates. The prevalence of S. 
aureus colonization among female inmates who were normal weight (BMI < 25 kg/m2) and had 
at least one marker of metabolic abnormal health status was 34% higher than the prevalence 
reported among individuals of normal weight with no metabolic abnormalities.  A similar but 
slightly lower increase in prevalence (28%) was observed amongst obese (BMI ≥ 30 kg/m2) 
females with one or more metabolic abnormality(s). No significant association was observed 
amongst overweight metabolically abnormal females. Neither normal weight nor overweight nor 
obese comorbid males with metabolic abnormalities demonstrated a significantly higher 
prevalence of S. aureus colonization as compared to normal weight metabolically healthy males. 
We did, however observe a significant increase in exclusive anterior nares colonization among 
obese male inmates with metabolic abnormalities as compared to metabolically healthy normal 
weight males. These findings partially support our hypothesis that metabolic abnormalities may 
be driving the observed association between obesity and S. aureus colonization, particularly 
among women.     
Our group10 and others8,9 have demonstrated an association between obesity and S. 
aureus colonization independent of diabetes. Olsen et al. was able to demonstrate an effect of 
obesity even after controlling for pre-diabetes.8 We expanded on these analyses by stratifying 
individuals by not only BMI category, but also metabolic health status to crudely test the 
hypothesis that abnormal metabolic health may be driving the observed association between 
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obesity and S. aureus colonization. In doing so we were able to demonstrate an effect of 
abnormal metabolic health on S. aureus colonization in the presence and absence of obesity, but 
no effect of BMI category when stratified by metabolic abnormalities. These findings not only 
contribute to the extant literature addressing the influence of obesity on infectious disease 
outcomes, but also to the literature attempting to understand the concepts of metabolically 
healthy and unhealthy obesity.48 As our study demonstrates, not all obese individuals present 
with increased cardio-metabolic risk; a proportion are metabolically healthy. This observation 
led to the development of a sub-phenotype of obesity referred to as metabolically healthy obese 
(MHO); characterized by their relative absence of metabolic complications.49 The estimated 
prevalence of MHO ranges from 13-30% of all obese individuals depending on the population 
assessed.30,49 Whether this phenotype represents a true subset or one end of a continuum is still 
under debate.49 However, MHO individuals have been shown to differ from their metabolically 
abnormal obese (MAO) counterparts on several different biological endpoints. For example, 
MHO individuals store energy preferentially through hypertrophy as compared to hyperplasia, 
present with a higher subcutaneous adipose tissue to vascular adipose tissue ratio, and have 
lower levels of inflammation than their metabolically abnormal counter parts.5,49 To our 
knowledge, we are the first to assess the influence of these obesity sub-phenotypes on an 
infectious disease outcome, and postulate that they could serve as mechanisms by which obesity 
impairs host defenses. Utilizing these sub-phenotypes in ID research as it relates to obesity might 
serve as a crude measure of the biological progression of obesity, and could introduce a degree 
of granularity in our estimates of the impact of obesity on infectious outcomes.   
Our sensitivity study restricting our assessments of metabolic health within categories of 
BMI demonstrated a significant increase in colonization in MANW as compared to MHNW, but 
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not for MAO as compared to MHO. As discussed above, studies assessing differences between 
sub-phenotypes of obesity have observed significant differences in risk in MAO as compared to 
MHO in certain conditions50,51 but not others.50 One of two explanations can account for our 
observation. First, similar to observations made with regards to MHO individuals as it relates to 
chronic non-communicable diseases such as diabetes and cardiovascular disease, the difference 
in the prevalence of S. aureus among MHO females as compared to MHNW, though non-
significant is not negligible, which is in accordance with previous observations.8 Second, the 
imprecision in our measure of metabolic health may be precluding our ability to detect a 
difference between healthy and abnormal obese individuals, and more precise measures using 
molecular markers of metabolic health may clarify the nature of the association. 
The mechanism by which metabolic abnormalities, both in the presence and absence of 
obesity, influence S. aureus colonization need to be elucidated. Many have cited increased levels 
of leptin and subsequent leptin resistance as potential pathways through which obesity influences 
infectious outcomes.6,7,52,53 This pathway is also plausible within the context of S. aureus 
colonization, as leptin has been shown to enhance the production of the anti-microbial peptides 
(AMP) such as human β-defensin-2 in human keratinocyte cell, which are known to line the 
anterior nares as well as other mucosal surfaces.54 Human β-defensin-2 is one of many AMPs 
that are constitutively expressed in keratinocytes that line the human nasal epithelium, and is one 
of a family of human β-defensin AMPs that have been shown to influence S. aureus 
colonization.21,55,56 Other underlying chronic diseases such as HIV, diabetes and hypertension are 
also associated with leptin levels,46 and could influence S. aureus colonization independently by 
this pathway or interact with one another to amplify the effect. Given that metabolic 
abnormalities are strongly associated with leptin resistance,5 our observation of increased 
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prevalence of S. aureus colonization among metabolically abnormal individuals aligns with this 
hypothesized pathway, and supports previous observations in animals57 implicating leptin in 
bacterial clearance from mucosal surfaces. It is important to note, that other factors such as 
25(OH)D levels, which are associated with obesity58 immune function,59,60 as well as S. aureus 
persistence18 may also play a role.  
We observed differences in the association between metabolic health and S. aureus 
colonization between men and women. These differences may be due to the sexual dimorphism 
in body fat distribution observed in obesity, which results from storage of excess energy in the 
form of triglycerides in the lipid droplets of adipocytes, the major cell type of adipose tissue. 
Two main subcategories of adipose tissue depots are recognized: subcutaneous adipose tissue 
and visceral adipose tissue. Subcutaneous adipose tissue is located between the dermis and fascia 
of muscle and is more prevalent amongst overweight/obese premenopausal females. Visceral 
adipose tissue is located within the intra- and extra peritoneal spaces of the abdomino-pelvic 
cavity and is more prevalent in post-menopausal women and males.44 Subcutaneous adipose 
tissue expresses higher levels of leptin, which could explain some of the sex differences 
observed.5,44 Furthermore, factors such as circulating sex hormones, which are altered differently 
in obese men as compared to women could also play a role.44 In an attempt to evaluate true 
biological differences of gender in the association between metabolic health and S. aureus 
colonization we used RERI methods to evaluate the possibility of biological synergism. No 
statistically significant evidence of biological synergism was observed. However, we were likely 
not sufficiently powered to detect true biological interaction.61 Future studies that are sufficiently 
powered should incorporate RERI methodology to evaluate biological interaction, when 
multiplicative models are used to evaluate the main effect of an exposure on an outcome.42 This 
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will not only help fully describe the associations under study, but provide useful indications of 
where interventions may have the most impact.62 Though the differences by sex could be 
biological in nature, we are unable to rule out the differences in the precision by which BMI 
captures adiposity in men and women as a potential explanation.63 For a given BMI, women 
have greater amounts of body fat than do men.64 Furthermore, BMI potentially misclassifies 
individuals with high muscle mass as overweight or obese, which may make BMI an imprecise 
measure of total adiposity in our male population.65 More granular measures of adiposity might 
clarify the underlying association between metabolic health and S. aureus colonization among 
both men and women.    
Another potential pathway by which obesity and other underlying medical conditions 
may affect infection/colonization with S. aureus is by causing a shift in the composition and/or 
abundance of microbial species in the human microbiome. As a commensal organism, S. aureus 
colonizes human epithelial surfaces without causing disease. Epithelial surfaces form the 
interface between the host and its exterior environment, and are therefore the main route of entry 
for microbial organisms.66 Important changes in epithelial tissue have been observed amongst 
obese individuals including alterations in barrier function and integrity, impaired wound healing, 
and increased susceptibility to infection.67 Evidence of epithelial dysfunction lies in the 
observation that the microbial composition of epithelial sites differ between obese and normal 
weight individuals, which has been posited to affect the pathogenicity of some of the residing 
organisms.68,69 Even more interesting, are recent findings suggesting microbial compositional 
changes at epithelial site observed in the presence of disease may be reflective of disease induced 
dysbiosis at other sites.70 Specifically, Zhang et al. observed that dysbiosis in gut microbial 
composition in the presence of rheumatoid arthritis was reflected in both the oral and saliva 
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microbiome.70 Furthermore, host genetic variation has been shown to influence microbial 
composition across different body sites71 lending credence to the hypothesis that dysbiosis at one 
site could be an indicator dysbiosis at other sites. More specific to our topic is the idea that the 
dysbiosis we observe in gut microbiota in obesity, may be an indication of shifts in the 
microbiome of other epithelial surfaces such as the anterior nares and/or oropharynx making 
those surfaces more susceptible to S. aureus colonization. This is supported by the fact that 
studies assessing S. aureus colonization within the context of the entire microbial composition of 
the anterior nares have linked distinct phylotypes to the presence or absence of the organism.72  
Results of the sensitivity analysis assessing the effect of misclassification of BMI 
category and comorbidity demonstrated that our findings for obese individuals with markers of 
metabolic abnormalities were somewhat robust to misclassification, however our findings for 
normal weight women with metabolic/immune dysfunction were not. The trend in the data was 
similar, but our effects were attenuated and failed to reach significance. Conversely, our 
sensitivity analysis removing HIV from our comorbidity construct support the robustness of our 
findings and demonstrate that markers of metabolic health alone could serve as proxies of 
metabolic dysfunction in the absence of more precise molecular measures such as elevated C-
reactive protein levels and elevated white blood cell.73  
We observed an association between site of colonization (exclusively anterior nares, 
exclusively oropharynx, both sites) and metabolic health status in men. This observation was 
surprising at first, given our findings of the main effect of metabolic health was restricted to 
women, however, they appeared more plausible when placed within the context of the existing 
literature. First, colonization site has been shown to differ by demographic factors, most notably 
age, race and gender.74,75 Individuals of Hispanic race/ethnicity were significantly more likely to 
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be exclusively colonized in the pharynx as are individuals of younger age and male sex.74,75 Our 
sample population differed also by clinical characteristics,76,77 suggesting that a subset of the 
population may be preferentially exclusively colonized at extra nasal sites, particularly the 
oropharynx. Few studies have assessed factors associated with S. aureus colonization site,74,75,77 
and those that have, had limited sample sizes and did not evaluate the influence of health 
characteristics on site of colonization. Given our findings, factors that influence site of 
colonization may warrant further assessment. Host factors associated with significant deviations 
from the established norm may be useful in identifying individuals who should be additionally 
screened in their oropharynx, as current practice requires only surveillance of the anterior nares. 
Finally, we are unable to rule out the fact that obese individuals, particularly those with 
comorbidities, may also engage in behavior that may predispose them to colonization such as 
less frequent or thorough hygiene due to limited mobility. Because overweight and obesity pose 
a significant public health concern in both adults and children, and the prevalence of metabolic 
abnormalities is higher among overweight and obese individuals, it is important that the pathway 
by which obesity and related chronic conditions influence S. aureus colonization be explicitly 
described so adequate measures can to be taken. This is especially pertinent in populations where 
the prevalence of overweight/obesity, metabolic chronic conditions and S. aureus colonization, is 
high.   
The present study has several limitations. Because of the cross-sectional nature of the 
study design, we are unable to ensure temporality of the exposure and outcome. It is unlikely, 
however, that colonization of the anterior nares by S. aureus predisposes individuals to metabolic 
abnormalities, though as discussed above, one cannot rule out an unmeasured factor such as a 
predisposing microbiome phylotype that may be driving the association. We also were limited by 
	
 78
the use of self-reported height and weight in our calculation of BMI, which then governed our 
classification of metabolic health. Both the inmates and the trained interviewers were blinded to 
the colonization status of the inmate at the time height and weight was ascertained, therefore any 
misclassification of BMI category is likely non-differential. In addition, comorbidities were 
assessed using the medical chart of patients, and therefore undiagnosed diseases were not 
included, again resulting in non-differential misclassification. Results of our sensitivity study 
demonstrated that our findings for MAO vs MHNW females were somewhat robust to 
misclassification, but not our findings for MANW vs MHNW females. Corroboration in different 
populations with regards to all findings is needed to rule out chance. Corroboration using more 
granular measures of metabolic health namely, blood pressure, fasting glucose, triglyceride level 
and high-density lipoprotein cholesterol is of particular interest. Moreover, as discussed above, 
the precision of BMI as a measure of adiposity differs across levels of gender in addition to other 
factors. This may have influenced our ability to detect a difference if individuals that were 
biologically normal with respect to fat mass were classified as obese.  
 Despite the limitations, the study still had several strengths. This study was the first to 
crudely assess the influence obesity sub-phenotypes on an infectious outcome. Furthermore, the 
study population was relatively large with considerable variability in both BMI and metabolic 
abnormalities, which enabled us to make robust estimates of the association controlling for 
numerous confounders. We included an analysis on site of colonization, and in doing so 
demonstrated that males that were obese with metabolic abnormalities were significantly more 
likely to be exclusively colonized in the anterior nares and less likely to exclusively colonized in 
the oropharynx supporting previous research with the same observation.74,76 
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In conclusion, our results indicate that metabolic/immune abnormalities that frequently 
accompany obesity are associated with S. aureus colonization and may play a role in 




Table 3.1. Definition of Obesity Phenotypes 
Characteristic BMI  Metabolic/Immune Comorbidities 
Metabolically Healthy Normal Weight  < 25 kg/m2 Normal – None 
Metabolically Abnormal Normal Weighta < 25 kg/m2 Abnormal – One or more  
Metabolically Healthy Overweight 25-29.9 kg/m2 Normal – None 
Metabolically Abnormal Overweight 25-29.9 kg/m2 Abnormal – One or more  
Metabolically Healthy Obese ≥ 30 kg/m2 Normal – None 
Metabolically Abnormal Obese ≥ 30 kg/m2 Abnormal – One or more  
Definitions: normal weight; body mass index (BMI) ≤ 24.9 kg/m2; overweight BMI 25-29.9 kg/m2; obese BMI ≥ 30.0 kg/m2 
Normal metabolic Health refers to absence of all of the following; hypertension, diabetes and human immune-deficiency virus 








Figure 3.1.  Diagram Illustrating the Methodology Used for the Monte Carlo Quantitative Bias Analysis of Misclassification 
	  
Figure 3.1 illustrates how the Monte Carlo simulation sensitivity study with bootstrapping methods assessing misclassification of body 
max index (BMI) category and metabolic health status was conducted. Using a uniform distribution 10% of the population was 
randomly selected and reclassified (blue arrow) independently for BMI category and metabolic health. The remaining individuals kept 
their observed classification (red arrow). The sample population was then reconstructed to reflect the hypothesized true distribution of 
both BMI category and metabolic health status (green column). The multivariable log-binomial regression model was subsequently 
fitted and the process repeated 1000 times. A summary measure reflecting the median estimate and standard error across all 
simulations was obtained.  
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Table 3.2 Descriptive Statistics of Factors Demographic, Behavioral Clinical Factors Associated with Staphylococcus aureus 
Colonization among Male and Female Maximum-Security Inmates 
























DEMOGRAPHICS                   
Age mean ± SD 36.4 ± 10.6 36.9 ± 10.9 0.34 34.7 ± 9.6 38.2 ± 10.8 <0.01 35.5 ± 10.1 37.5 ± 10.8 <0.01 
Female Gender N/A N/A N/A N/A N/A N/A 612 (45.8) 745 (49.8) 0.04 
Race     0.72     0.68     0.40 
Non-Hispanic White 200 (32.7) 249 (32.7)   78 (10.8) 76 (10.1)   278 (20.8) 325 (21.7)   
Non-Hispanic Black 261 (42.7) 328 (44.0)   390 (54.0) 429 (57.2)   651 (48.8) 757 (50.6)   
Hispanic 108 (17.7) 114 (15.3)   216 (29.9) 209 (27.9)   324 (24.3) 323 (21.6)   
Other 43 (7.0) 54 (7.3)   38 (5.3) 36 (4.8)   81 (6.1) 90 (6.0)   
Education     0.04     <0.01     0.34 
< High school 203 (33.2) 200 (26.9)   235 (32.6) 276 (36.8)   438 (32.8) 476 (31.8)   
High School/Equivalent 195 (31.9) 257 (34.5)   288 (39.9) 324 (43.2)   483 (36.2) 581 (38.9)   
> High school 214 (35.0) 288 (38.7)   199 (27.6) 150 (20.0)   413 (31.0) 438 (29.3)   
BEHAVIOR                   
Smoking 415 (67.8) 518 (69.5) 0.50 437 (60.5) 470 (62.3) 0.44 852 (63.9) 988 (66.1) 0.22 
Marijuana Use in Past 
6 Months 
75/610 (12.3) 64/739 (8.7) 0.03 93/717 
(13.0) 
81/747 (10.8) 0.21 168/1,328 
(12.6) 
145/1485 (12.6) 0.02 








570/1,490 (38.3) 0.47 




98/749 (13.1) 0.19 230/1,329 
(17.3) 
231/1492 (15.5) 0.19 
History of IDU 91/606 (15.0) 84/731 (11.5) 0.06 31/717 (4.3) 46/745 (6.2) 0.11 122/1323 (9.2) 130/1,476 (8.8) 0.70 
Shares Personal Items 93 (15.2) 93 (12.5) 0.15 53 (7.3) 58/749 (7.7) 0.77 146 (11.0) 151/1494 (10.1) 0.47 




458/1486 (30.8) 0.06 
Prison time (days) N 
(mean ± SD) 
612 (691 ± 
1,432) 
744 (676 ± 
1,315) 
0.83 717 (1,364 ± 
1,824) 




1,326 (1,054 ± 
1,689) 






MEDICAL                   
BMI mean ± SD 29.8 ± 6.6 29.3 ± 6.8 0.13 27.9 ±4.4 27.8 ± 4.6 0.78 1,334 (28.5 ± 
5.6) 
1,495 (28.5 ± 
5.8) 
0.29 
Diabetes 64 (10.5) 63 (8.5) 0.21 33 (4.6) 28 (3.7) 0.42 97 (7.3) 91 (6.1) 0.21 
Hypertension 129 (21.1) 133 (17.9) 0.13 107 (14.8) 142 (18.9) 0.04 236 (17.7) 275 (18.4) 0.63 
HIV  36 (5.9) 45 (6.0) 0.90 17 (2.4) 17 (2.3) 0.91 53 (4.0) 62 (4.2) 0.69 
Abnormal Metabolic 
Health 
177 (28.9) 193 (25.9) 0.21 133 (18.4) 166 (22.1) 0.08 310 (23.2) 359 (24.0) 0.63 
HCV 84 (13.7) 92 (12.4) 0.45 39 (5.4) 67 (8.9) 0.01 123 (9.2) 159 (10.6) 0.18 
Liver Disease 95 (15.5) 97 (13.0) 0.19 46 (6.4) 77 (10.3) 0.01 141 (10.6) 174 (11.6) 0.37 
Asthma 221 (36.1) 278 (37.3) 0.65 195 (27.0) 185 (24.7) 0.30 416 (31.0) 463 (31.1) 0.90 
Kidney Disease  15 (2.5) 21 (2.8) 0.67 8 (1.1) 15 (2.0) 0.17 23 (1.7) 36 (2.4) 0.20 








462/1472 (31.4) 0.05 




92/737 (12.5) 0.05 234/1282 
(18.3) 
211/1470 (14.4) 0.01 
INCARCERATION CHARACTERISTICS 
Length of Stay      <0.01      <0.01     <0.01 
≤ 20 days 214 (35.0) 189 (25.4)   84 (11.6) 42 (5.6)   298 (22.3) 231 (15.5)   
21-3,000 Days 351 (57.4) 515 (69.1)   530 (73.4) 550 (73.3)   881 (66.0) 1,065 (71.2)   
> 3,000 Days 47 (7.7) 41 (5.5)   108 (15.0) 158 (21.1)   155 (11.6) 199 (13.3)   
Study Phase     <0.01     <0.01     <0.01 
Intake 194 (31.7) 176 (23.6)   225 (31.2) 160 (21.3)   419 (31.5) 336 (22.5)   
Prevalence 263 (43.0) 349 (46.9)   340 (47.1) 430 (57.3)    603 (45.2) 779 (52.1)   
Discharge 155 (25.3) 220 (29.5)   157 (21.8) 160 (21.3)   312 (23.4) 380 (25.4)   
Definitions: normal weight; body mass index (BMI) ≤ 24.9 kg/m2; overweight BMI 25-29.9 kg/m2; obese BMI ≥ 30.0 kg/m2; IDU: 
injection drug use; HIV; human immunodeficiency virus; HCV: hepatitis C virus 
a “Other” category includes Asian, Native Americans, Pacific Islander and persons of or two or more racial/ethnic groups 





Table 3.3. Descriptive Statistics of Demographic and Staphylococcus aureus Colonization Status of Male and Female Maximum-
Security Inmates Stratified by Comorbidity Status  
























Female             
Age mean age ± SD 33.7 ± 10.4 45.0 ± 10.2 33.6 ± 10.2 43.8 ± 9.7 35.1 ± 9.9 42.8 ± 9.1 
Race             
Non-Hispanic White 138 (45.7) 22 (36.1) 124 (37.1) 24 (24.0) 101 (28.8) 40 (19.1) 
Non-Hispanic Black 87 (28.8) 29 (47.5) 132 (39.5) 54 (54.0) 162 (46.1) 125 (59.8) 
Hispanic 45 (14.9) 6 (9.8) 56 (16.7) 17 (17.0) 66 (18.8) 32 (15.3) 
Othera 32 (10.6) 4 (6.6) 22 (6.6) 5 (5.0) 22 (6.3) 12 (5.7) 
Education             
< High school 83 (27.5) 12 (21.3) 88 (26.3) 30 (30.0) 114 (32.5) 75 (35.9) 
High School/Equivalent 106 (35.1) 24 (39.3) 107 (32.0) 33 (33.0) 124 (35.3) 58 (27.7) 
> High school 113 (37.4) 24 (39.3) 139 (41.6) 37 (37.0) 113 (32.2 76 (36.4) 
Smoking 217 (71.8) 38 (62.3) 217 (65.0) 73 (73.0) 240 (68.4) 148 (70.8) 
S. aureus Colonization       
Colonized 119 (39.4) 31 (50.8) 154 (46.1) 41 (41.0) 162 (46.1) 105 (50.2) 
Exclusively anterior nares 34 (28.6) 11 (35.5) 46 (29.9) 13 (31.7) 46 (28.4) 43 (40.9) 
Exclusively oropharynx 50 (42.0) 8 (25.8) 66 (42.9) 13 (31.7) 69 (42.6) 30 (28.6) 
Both sites 35 (29.4) 12 (38.7) 42 (27.3) 15 (36.6) 47 (29.0) 32 (30.5) 
Male        
Age N (mean ± SD) 32.3 ± 9.4 45.6 ± 11.5 35.0 ± 9.6 44.6 ± 10.4 36.5 ± 9.2 42.2 ± 9.1 
Race             
Non-Hispanic White 28 (8.9) 4 (8.5) 66 (11.0) 16 (12.6) 28 (10.8) 12 (9.6) 
Non-Hispanic Black 180 (57.0) 26 (55.3) 310 (51.7) 81 (63.8) 137 (53.1) 85 (68.0) 




Othera 19 (6.0) 1 (2.1) 40 (6.7) 3 (2.4) 9 (3.5) 2 (1.6) 
Education             
< High school 125 (39.6) 21 (44.7) 196 (32.7) 35 (27.6) 95 (36.8) 39 (31.2) 
High School/Equivalent 130 (41.1) 14 (29.8) 260 (43.4) 52 (40.9) 105 (40.7) 51 (40.8) 
> High school 61 (19.3) 12 (25.5) 143 (23.9) 40 (31.5) 58 (22.5) 35 (28.0) 
Smoking 204 (64.6) 32 (68.1) 362 (60.4) 74 (58.3) 169 (65.5) 66 (52.8) 
S. aureus Colonization       
Colonized 149 (47.1) 20 (42.5) 307(51.3) 52 (40.9) 133 (51.5) 61 (48.8) 
Exclusively anterior nares 24 (16.1) 9 (45.0) 67 (21.8) 17 (32.7) 34 (25.6) 27 (44.3) 
Exclusively oropharynx 82 (55.0) 8 (40.0) 20 (38.5) 20 (38.5) 53 (39.9) 26 (42.6) 
Both sites 43 (28.9) 3 (15.0) 15 (28.9) 15 (28.9) 46 (34.6) 8 (13.1) 
Definitions: normal weight; body mass index (BMI) ≤ 24.9 kg/m2; overweight BMI 25-29.9 kg/m2; obese BMI ≥ 30.0 kg/m2 
a “Other” category includes Asian, Native Americans, Pacific Islander and persons of or two or more racial/ethnic groups 





Table 3.4. Multivariable Log Binomial Regression depicting the Independent Effect of Comorbidity Status on Staphylococcus aureus 
Colonization 
    Prevalence Ratio (95% Confidence Interval) 
Metabolic Health Status BMI Status  Colonization with Staphylococcus aureus 
    Female Male 
    Unadjusted Adjusted Unadjusted Adjusted 
Healthy Normal Weight Reference Reference Reference Reference 
  Overweight 1.17 (0.97, 1,40) 1.14 (0.95, 1.36) 1.09 (0.94, 1.24) 1.09 (0.95, 1.25) 
  Obese 1.17 (0.98, 1.40) 1.12 (0.94, 1.36) 1.09 (0.93,1.29) 1.15 (0.98, 1.35) 
Abnormal Normal Weight 1.29 (0.97, 1.71) 1.34 (1.01, 1.77) 0.90 (0.63,1.28) 1.18 (0.83, 1.67) 
  Overweight 1.04 (0.79, 1.37) 1.11 (0.84, 1.47) 0.86 (0.68, 1.10) 1.03 (0.81, 1.30) 
  Obese 1.27 (1.05, 1.55) 1.28 (1.05, 1.57) 1.03 (0.84, 1.28) 1.21 (0.97, 1.51) 
Abbreviations: PR, Prevalence ratio; 95%CI, 95% confidence intervals 
Definitions: normal weight; body mass index (BMI) ≤ 24.9 kg/m2; overweight BMI 25-29.9 kg/m2; obese BMI ≥ 30.0 kg/m2 
aControlling for age, race, education, smoking, study phase, marijuana use in the past six months, heroin use, injection drug use, 
systemic and topical antibiotic use 
bControlling for age race, education, smoking, phase, drug use ever, hepatitis C virus infection, systemic and topical antibiotic use 
cMetabolically abnormal health was defined as the diagnosis of one or more of the following: hypertension, diabetes and human 




Table 3.5. The Role of Comorbidity Status on Site of Staphylococcus aureus Colonization among Colonized New York State 
Maximum-Security Inmates  
    Adjusted Odds Ratio (95% Confidence Interval) 
Metabolic Health Status BMI Status  Colonization with Staphylococcus aureus 
    Femalea Maleb 
    Nose Vs Throat Both Sites vs. Throat Nose vs Throat Both Sites vs. Throat 
Healthy Normal Weight Reference Reference Reference Reference 
  Overweight 1.04 (0.57, 1.88) 0.90 (0.50, 1.62) 1.23 (0.71, 2.15) 0.97 (0.60, 1.15) 
  Obese 0.82 (0.45, 1.48) 0.93 (0.52, 1.67) 1.66 (0.86, 3.20) 1.55 (0.88, 2.73) 
Unhealthy Normal Weight 1.20 (0.41,3.45) 1.75 (0.62, 5,01) 2.24 (0.70, 7.19) 0.63 (0.15, 2.65) 
  Overweight 0.93 (0.37, 2.36) 1.49 (0.60, 3.68) 1.69 (0.73, 3.96) 1.28 (0.57, 2.89) 
  Obese 1.29 (0.65, 2.57) 1.28 (0.63, 2.60) 2.40 (1.13, 5.09) 0.61 (0.25, 1.53) 
Abbreviations: OR, odds ratio; 95% CI, 95% confidence intervals 
Definitions: normal weight; body mass index (BMI) ≤ 24.9 kg/m2; overweight BMI 25-29.9 kg/m2; obese BMI ≥ 30.0 kg/m2 
aControlling for age, phase, drug (marijuana, crack/cocaine, and or heroine) use ever & hepatitis C virus infection  
bControlling for age race, drug (marijuana, crack/cocaine, and or heroine) use ever & hepatitis C virus infection  
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Table A3.1 Sensitivity Analysis Assessing 10% Misclassification of Body Mass Index Category and Independently 10% 
Misclassification of Metabolic Health Status in the Association between Metabolic Health Status and Staphylococcus aureus 
colonization 
Metabolic Health Statusc  BMI Status   Prevalence Ratio (95% Confidence Interval) 
      Femalea  Maleb 
      Adjusted  Adjusted 
Healthy  Normal Weight  Reference  Reference 
   Overweight  1.15 (0.89, 1.42) 1.11 (089, 1.33) 
   Obese  1.15, (0.90, 1.42) 1.15 (0.91, 1.40) 
Abnormal  Normal Weight  1.19 (0.84, 1.53) 1.08 (0.68, 1.49) 
   Overweight  1.15 (0.81, 1.50) 1.07 (076, 1.36) 
   Obese  1.28 (1.00, 1.56) 1.18 (0.89, 1.47) 
Abbreviations: BMI; body mass index  
Definitions: normal weight BMI ≤ 24.9 kg/m2; overweight BMI 25-29.9 kg/m2; obese BMI ≥ 30.0 kg/m2 
aControlling for age, race, education, smoking, study phase, marijuana use in the past six months, heroin use, injection drug use, 
systemic and topical antibiotic use 






Figure A3.1 Sensitivity Analysis Assessing the Impact of Missing Data on Study Parameters Using Multiple Imputation Methods 
among Female Maximum-Security Inmates 
 
Abbreviations: PR, Prevalence Ratio; 95%CI, 95% confidence intervals  
Definitions: normal weight; body mass index (BMI) ≤ 24.9 kg/m2; overweight BMI 25-29.9 kg/m2; obese BMI ≥ 30.0 kg/m2 
All models controlling for age, race, education, smoking, study phase, marijuana use in the past six months, heroin use, injection drug 
use, systemic and topical antibiotic use 




Available: Only observations with complete exposure and outcome data were assessed imputing missing covariate where required 




Figure A3.2 Sensitivity Analysis Assessing the Impact of Missing Data on Study Parameters Using Multiple Imputation Methods 
among Male Maximum-Security Inmates 
 
Abbreviations: PR, Prevalence Ratio; 95%CI, 95% confidence intervals  
Definitions: normal weight; body mass index (BMI) ≤ 24.9 kg/m2; overweight BMI 25-29.9 kg/m2; obese BMI ≥ 30.0 kg/m2 
All models controlling for age, race, education, smoking, study phase, marijuana use in the past six months, heroin use, injection drug 
use, systemic and topical antibiotic use 




Available: Only observations with complete exposure and outcome data were assessed imputing missing covariate where required 





Table A3.2 Multivariable Log Binomial Regression depicting the Independent Effect of Abnormal Metabolic/Immune Status 
(Hypertension & Diabetes) on Staphylococcus aureus Colonization 
    Prevalence Ratio (95% Confidence Interval) 
Metabolic Health Statusc BMI Status  Colonization with Staphylococcus aureus 
    Femalea Maleb 
    Adjusted Unadjusted Adjusted Unadjusted 
Healthy Normal Weight Reference Reference Reference Reference 
  Overweight 1.11 (0.93, 1.33) 1.11 (0.934, 1.33) 1.07 (0.93, 1.22) 1.07 (0.94, 1.24) 
  Obese 1.10 (0.91, 1.31) 1.08 (0.91, 1.29) 1.09, 0.92, 1.29) 1.14 (0.97, 1.34) 
Abnormal Normal Weight 1.23 (0.89, 1.71) 1.39 (1.01, 1.91) 0.85 (0.57,, 1.28) 1.11 (0.74, 1.66) 
  Overweight 1.04 (0.77, 1.39) 1.12 (0.84, 1.52) 0.87 (0.68, 1.11) 1.04 (0.82, 1.32) 
  Obese 1.26 (1.05, 1.54) 1.33 (1.09, 1.64) 1.03, 0.82, 1.27) 1.19 (0.96, 1.48) 
Abbreviations: BMI; body mass index  
Definitions: normal weight BMI ≤ 24.9 kg/m2; overweight BMI 25-29.9 kg/m2; obese BMI ≥ 30.0 kg/m2 
aControlling for age, race, education, smoking, study phase, marijuana use in the past six months, heroin use, injection drug use, 
systemic, topical antibiotic use and Human Immunodeficiency Virus 
bControlling for age race, education, smoking, phase, drug use ever, hepatitis C virus infection, systemic, topical antibiotic use and 
Human Immunodeficiency Virus 


















Diabetes, & HIV Total 
Female         
Normal Weight & 
Comorbid 




4 (44.7) 15 (16.0) 17 (18.1) 12 (12.8) 5 (5.3) 2 (2.1) 1 (1.1) 94 
Obese & Comorbid 97 (48.0) 25 (12.4) 17 (8.4) 47 (23.3) 7 (3.5) 5 (3.5) 4 (2.0) 202 
Total 167 48 49 62 16 7 5 354 
Male                 
Normal Weight & 
Comorbid 




91 (71.6) 11 (8.7) 10 (7.9) 11 (8.7) 4 (3.1) 0 0 
127 
Obese & Comorbid 86 (70.5) 10 (8.2) 4 (3.3) 19 (15.6) 1 (0.8) 1 (0.8) 1 (0.8) 122 
Total 204 26 23 31 8 1 2  
Definitions: normal weight; body mass index (BMI) ≤ 24.9 kg/m2; overweight BMI 25-29.9 kg/m2; obese BMI ≥ 30.0 kg/m2;  HIV, 
human immune-deficiency virus 
a “Other” category includes Asian, Native Americans, Pacific Islander and persons of or two or more racial/ethnic groups 





Table A3.4 Multivariable Log Binomial Regression depicting the Independent Effect of Abnormal Metabolic/Immune Status (2+ 
Comorbidities) on Staphylococcus aureus Colonization 
    Prevalence Ratio (95% Confidence Interval) 
Metabolic Health Statusc BMI Status  Colonization with Staphylococcus aureus 
    Femalea Maleb 
    unadjusted Adjusted unadjusted Adjusted 
Healthy Normal Weight Reference Reference Reference Reference 
  Overweight 1.09 (0.92, 1.28) 1.09 (0.93, 1.28) 1.06 (0.93, 1.22) 1.07 (0.94, 1.22) 
  Obese 1.10 (094, 1.29) 1.09 (0.93, 1.28) 1.07 (0.92, 1.25) 1.14 (0.99, 1.32) 
Abnormal Normal Weight 1.35 (0.70, 2.60) 1.58 (0.79, 3.12) 1.28 (0.62, 2.65) 1.81 (0.86, 3.80) 
  Overweight 0.83 (0.45, 1.52) 0.91 (0.49, 1.68) 0.85 (0.46, 1.61) 1.01 (0.54, 1.90) 
  Obese 1.31 (1.02, 1.69) 1.40 (1.067, 1.84) 1.17 (0.79, 1.74) 1.31 (0.89, 1.92) 
Abbreviations: BMI; body mass index  
Definitions: normal weight BMI ≤ 24.9 kg/m2; overweight BMI 25-29.9 kg/m2; obese BMI ≥ 30.0 kg/m2 
aControlling for age, race, education, smoking, study phase, marijuana use in the past six months, heroin use, injection drug use, 
systemic and topical antibiotic use  
bControlling for age race, education, smoking, phase, drug use ever, hepatitis C virus infection, systemic and topical antibiotic use  





Table A3.5 Alternative Analysis Assessing the Association between Abnormal Metabolic Health and Colonization with 
Staphylococcus aureus: The Influence of BMI within Metabolic Health Categories 
    Odds Ratio (95% Confidence Interval) 
Metabolic Health Statusc BMI Category  Colonization with Staphylococcus aureus 
    Femalea Maleb 
Model 1 - Healthy Normal Weight Reference Reference 
  Overweight 1.31 (0.94, 1.82) 1.27 (0.95, 1.70) 
  Obese 1.28 (0.92, 1.78) 1.38, 0.97, 1.97) 
Model 2- Unhealthy Normal Weight Reference  Reference  
  Overweight 0.70 (0.35, 1.40) 0.85 (0.41, 1.77) 
  Obese 0.90 (0.49, 1.67) 1.13 (0.53, 2.36)  
Abbreviations: BMI; body mass index  
Definitions: normal weight BMI ≤ 24.9 kg/m2; overweight BMI 25-29.9 kg/m2; obese BMI ≥ 30.0 kg/m2 
aControlling for age, race, education, smoking, study phase, marijuana use in the past six months, heroin use, injection drug use, 
systemic and topical antibiotic use  
bControlling for age race, education, smoking, phase, drug use ever, hepatitis C virus infection, systemic and topical antibiotic use  
cAbnormal Metabolic health defined by the diagnosis of two or more of the following: hypertension, diabetes and/or HIV 
Among women: N total = 1,310, N among healthy = 956 (425 staph positive), N among unhealthy = 354 (173 staph positive) 





Table A3.6 Alternative Analysis Assessing the Association between Abnormal Metabolic Health and Colonization with 
Staphylococcus aureus: The influence of Metabolic Health within BMI Categories 
    Prevalence Ratio (95% Confidence Interval) 
BMI Category Metabolic Health Statusc Colonization with Staphylococcus aureus 
    Femalea$ Maleb& 
Model 1 - Normal Weight Healthy Reference Reference 
  Unhealthy 2.15 (1.11, 4.18) 1.47 (0.71, 3.05) 
Model 2 - Overweight Healthy Reference Reference  
  Unhealthy 0.93 (0.54, 1.59) 0.87 (0.56, 1.34) 
Model 3 - Obese Healthy  Reference Reference  
  Unhealthy 1.16 (0.79, 1.72)  1.00 (0.62, 1.63)  
Abbreviations: BMI; body mass index  
Definitions: normal weight BMI ≤ 24.9 kg/m2; overweight BMI 25-29.9 kg/m2; obese BMI ≥ 30.0 kg/m2 
aControlling for age, race, education, smoking, study phase, marijuana use in the past six months, heroin use, injection drug use, 
systemic and topical antibiotic use  
bControlling for age race, education, smoking, phase, drug use ever, hepatitis C virus infection, systemic and topical antibiotic use  
cAbnormal Metabolic health defined by the diagnosis of two or more of the following: hypertension, diabetes and/or HIV 
Normal weight women N total=343, Normal weight men N total = 351; Overweight women total = 420, Overweight men = 712; 
Obese women total = 547, Obese men total N = 372 
$P for interaction between metabolic health and normal weight among women was marginally significant (0.083) and not significant 










CHAPTER 4: Obesity and Persistent Colonization with Staphylococcus aureus 
 
INTRODUCTION 
Staphylococcus aureus remains an important human pathogen, causing relatively benign 
infections such as skin and soft tissue infections (SSTIs) as well as serious conditions such as 
necrotizing pneumonia and endocarditis.1 Despite its capacity to cause invasive diseases, the 
organism can also benignly reside as a transient and sometimes persistent component of the 
resident flora of different human mucosal sights, including the anterior nares,2 oropharynx,3,4 
skin, gastro-intestinal tract5 and inguinal areas.6 Colonization of these mucosal sites, particularly 
the anterior nares, is associated with subsequent infection by the colonizing strain,7 and 
individuals that are persistently colonized are at elevated risk of infection.7 Studies also show 
that persistently colonized individuals or persistent carriers have a higher nasal bacterial load 
than intermittent or non carriers,5,8,9 thereby contributing more substantially to the organisms 
dispersion and transmission.10 The mechanisms by which S. aureus becomes a persistent 
component of the nasal microbial flora are still largely unknown. Identifying modifiable host 
factors that contribute to persistent carriage will not only identify individuals at risk of infection, 
but also help identify those that more efficiently disseminating the organism thereby placing 
others at risk of infection.  
Although the definition varies, persistent carriers are most frequently described as 
individuals in whom S. aureus is isolated in over 80% of cultures taken weekly over a period of 
approximately three months,11 or individuals with two positive S. aureus culture taken one week 
apart.8 An estimated 20% of individuals in the general population are considered persistent 
carriers,12 and the remainder are defined as Intermittent carriers. The Intermittent carriage 
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phenotype is comprised of individuals in whom < 80% of cultures obtained are positive for S. 
aureus, or those historically classified as intermittent carriers, as well as those who are 
consistently culture negative, or those historically defined as non-carriers.9,11 Individuals 
historically classified as intermittent carriers or non-carriers now comprise one phenotypic group 
because they demonstrate similar characteristics that are distinct from those demonstrated by 
persistent carriers. For example, upon artificial inoculation, the rate of S. aureus clearance 
among intermittent and non-carriers were similar and also statistically significantly different than 
persistent carriers.13 Furthermore, despite being inoculated with a mixture of different strains, 
persistent carriers reverted back to their original colonizing strains whereas intermittent and non-
carriers displayed no affinity to a particular strain.13 Lastly, persistent carriers displayed a lower 
exchange rate of S. aureus clones over time as compared to intermittent or non-carrier either in 
artificial inoculation environments or in strictly observational settings.13-15 These data 
demonstrate that a small but substantial subset of the population interacts with S. aureus 
differently and reasons for those differences need to be elucidated.  
Demographic and behavioral factors such as younger age16,17, male sex16 and 
contraceptive use 18 are all positively associated with persistent carriage whereas smoking16 has 
been shown to be protective. More importantly, a number of local and systemic immune factors 
have been shown to influence S. aureus carriage type. For example, antimicrobial peptide levels, 
which are both constitutively and inducibly expressed in the anterior nares as well as other 
mucosal sites are lower in persistent carriers as compared to intermittent.19 In addition, serum 
25hydroxyvitaminD (25(OH)D levels are significantly lower among persistent carriers, though 
this observation was restricted to males.16 Also associated with persistent carriage are 
polymorphisms in genes that control the expression of the antimicrobial peptide β-defensin 1 
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messenger RNA expression20 as well as polymorphisms in genes expressing C-reactive protein 
and Interleukin-421 (IL-4).  
Many of the above systemic and local immune factors associated with persistent carriage 
are also altered in obesity. For example, levels of circulating IL-4, which is associated with an 
anti-inflammatory Th2 immune profile,22-24 is lower in obese individuals. In addition 25(OH)D is 
currently viewed as central to a host’s defense against infection,25 however, circulating levels 
have been shown to significantly lower among obese as compared to normal weight 
individuals.26 Lastly, leptin, an immune-modulatory adipokine that regulates antimicrobial 
peptide secretions both in vitro and in vivo has been shown to influence intestinal microbial 
composition in mouse models27 and its receptor are expressed in the human nasal mucosa.28 
Leptin dysfunction in both adipose tissue and peripheral blood is a hallmark of obesity29 and it 
has been implicated in the impaired host defenses observed amongst the obese.30  
The data clearly demonstrates that both innate and adaptive immunity are associated with 
persistent S. aureus carriage, particularly in the anterior nares, and many of these factors are also 
independently associated with obesity. The extent to which these responses are influenced by 
obesity has yet to be investigated. Furthermore, the influence of ancillary colonization sites such 
as the oropharynx on the carrier patterns observed has not been extensively assessed in non-
clinical settings.31-33 Recent findings have highlighted the importance of persistent S. aureus 
carriage of the GI tract5,34 as well as the oropharynx to subsequent disease. It is, therefore, 
increasingly important to assess bacterial and host factors that contribute to the organism’s 
persistence not only in the anterior nares but other frequently colonized mucosal sites.  
 In an attempt to characterize S. aureus persistence in both the anterior nares and the 
oropharynx we used data from a recently completed study characterizing S. aureus colonization 
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among New York state inmates to determine the prevalence of persistent carriage among this 
high risk group.35 Our primary aim was to examine the association between obesity and 
persistent S. aureus carriage as well as to characterize differences in persistent nasal as compared 
to oropharynx carriage. We hypothesized that obesity, which others36 and our group37 have 
shown to be prevalent in incarcerated population, more particularly NY state inmates,37 will be 
associated with persistent S. aureus carriage. We further described the carriage phenotypes by 
assessing strain diversity and compositional differences across the different carriage types using 
Simpson’s Index of diversity as well as correspondence analysis.  
METHODS 
Setting and Sample  
Data from an NIH-funded study (5R01AI082536) of S. aureus prevalence and risk 
factors in two NYS maximum-security prisons, Bedford Hills Correctional Facility (women’s 
prison) and Sing Sing Correctional Facility (men’s prison), were used. Both participating 
facilities are located in Westchester county New York (NYS). The female prison is located in the 
town of Bedford Hills and is the only female maximum-security prison in NYS.  It has the 
capacity to house approximately 900 inmates, and serves as the only female prison reception 
center in NYS and therefore all females entering into the NYS prison system are admitted to this 
facility before being transferred to their designated confinement facility. In contrast, the male 
prison is one of 15 male maximum-security prisons in NYS, and has the capacity to house 
approximately 1800 inmates. It is located in the town of Ossining and most inmates that reside in 
the facility have been transferred from other prisons. Study data were collected in three distinct 
phases: (1) when inmates entered the facility (intake), (2) at any time point during incarceration 
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(cross-sectional), (3) when inmates were being released back into the general population 
(discharge).  
Participant Recruitment  
Participant recruitment began in January 2009 and ended in February 2014. Inmate 
participation at both facilities was voluntary and compensation was not provided. Eligible 
participants were inmates ages 16 years or older capable of providing informed consent. The 
Institutional Review Boards of Columbia University Medical Center (CUMC) and the New York 
State Department of Corrections and Community Supervision (DOCCS) approved the study.  
To recruit participants for intake, inmates entering either the female or the male prisons 
were invited to participate in the study when they first entered the facility and while being 
processed. One of five trained research associates from CUMC invited the inmates to speak with 
them in a private room. At this time, inmates were provided with a brief description of the study 
and informed consent was solicited along with Health Insurance and Portability and 
Accountability Act (HIPAA) release. Recruitment for the cross-sectional phase varied by prison 
facility. In the female prison, inmates were called to the facility medical center and invited to 
participate. To recruit participants in the male prison trained research associates visited 
classrooms in the school, vocational training, and counseling buildings, and asked inmates if they 
were interested in participating in the study. At both facilities, interested inmates were 
subsequently invited to speak with a trained research associate from CUMC in a private room 
and were enrolled in the cross-sectional phase if informed consent was provided. Recruitment for 
the discharge phase was similar for both facilities; inmates were called to the facility medical 
center and invited to speak privately with a trained research associate.  
Data Collection and Extraction 
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Trained research associates used a structured questionnaire to interview participants and 
collect demographic, behavioral and medical history information. During the interview, 
participants were cultured at the anterior nares and oropharynx, and culture swabs were later 
processed to assess asymptomatic colonization with S. aureus. In addition, research associates 
extracted data from the medical charts of inmates focusing on the NYS DOCCS Health Services 
System problem list and the provider’s progress notes.  
Medical conditions were included in an inmate’s Health Services System problem list 
during intake processing and/or anytime during incarceration. Upon entry into DOCCS, each 
inmate undergoes a medical screening process that includes a detailed medical history, blood 
tests, dental and chest X-ray. In addition, every inmate is offered a human immunodeficiency 
virus (HIV) test at prison entry, and those at risk for hepatitis C virus (HCV) based on medical 
and drug history screenings are tested for the condition. Medical conditions of note at screening 
are included in the Health Services System problem list, or are included in the progress notes in 
an inmate’s medical chart.  In addition, any medical condition identified during incarceration 
was included in the problem list and /or the progress notes along with any medical procedures 
and/or laboratory tests conducted while incarcerated.  
Study Design 
The sample population used to assess the association between obesity and persistent S. 
aureus carriage represents a subset of the entire study sample described above. Specifically, 
though the parent study was not designed to be a longitudinal study, 274 inmates were 
interviewed and cultured on at least two different occasions during the course of the study. This 
subset was used to generate a longitudinal data set reflecting inmates’ carriage patterns over 
time. This data set was then used to examine factors associated with persistent colonization.  
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Outcome Assessment: Persistent S. aureus Colonization  
S. aureus characterization for each time of assessment was carried out as previously 
described.31 Swab samples obtained from the anterior nares and oropharynx of participants were 
incubated overnight in 6% sodium chloride-supplemented tryptic soy broth (Becton Dickinson) 
at 35°C. This particular broth was used to enrich S. aureus selection. Aliquots of the broth were 
then plated onto mannitol salt agar (Becton Dickinson) and incubated for 48 hours at 37°C. 
Individual colonies on the salt agar plates that were morphologically identified as S. aureus were 
streaked onto sheep blood agar plates and subsequently confirmed as S. aureus using the 
coagulase and protein A detection kit (Murex Staphaurex, Lenexa, KA). Confirmed isolates were 
then characterized by spa typing and compared using Ridom Staph Type software (Ridom 
GmBH). In order to determine the clonal relatedness of the different of S. aureus strains 
identified in the population, spa types were clustered into spa clonal complexes (spa-CC) using 
Based Upon Repeat Pattern (BURP) analysis.38 All S. aureus isolates from which spa types were 
obtained and further had five or more repeats will be included in the BURP analysis. BURP 
analysis results in the assignment of each spa-type included in the analysis to a specific spa-CC. 
The spa-CC a specific S. aureus strain is assigned is dependent on all the spa types included in 
the analysis. 
The outcome of interest was persistent colonization (yes/no) with S. aureus, which was 
defined two ways. The first method of assessing persistent S. aureus colonization was at the 
species level, i.e., inmates colonized with S. aureus at the anterior nares or oropharynx at all time 
points (usually two) in which they were assessed. Table 4.1 describes the different patterns of 
colonization that were observed over time and the nomenclature used to describe the pattern. The second 
method of assessing persistent S. aureus colonization was at the strain level, i.e., inmates 
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colonized with same S. aureus strain at the anterior nares or oropharynx at all of the time points 
in which they were assessed. We assessed both methods based on findings in chapter one of this 
dissertation suggesting that two different populations of persistent carriers may exist. Species 
persistence captures both populations in that that it is inclusive of individuals who are 
consistently colonized due to frequent exposure or decreased ability to prevent or clear carriage 
as well as those who display the biological characteristics (i.e. higher bacterial load, longer strain 
carriage, symbiotic relationship with colonizing strain) frequently associated persistent carriage. 
Strain persistence restricts our attention to the latter group. The majority of inmates included in 
this data set were assessed a maximum of two times, and therefore only two swabs cultures were 
used to determine persistent colonization in these individuals. This method has been frequently 
used to assess persistent S. aureus colonization, resulting in similar rates of persistent carriage 
across studies.8,17,39,40  
Exposure Assessment: Obese 
Obesity at each time of assessment was assessed by first calculating the BMI of each 
inmate based on self-reported height and weight using the following equation 
	 	
	703 . Inmates were then categorized as being obese defined as having a BMI ≥ 30 kg/m2 or 
non-obese inmates (BMI < 30 kg/m2). Individuals found to be obese at one point of assessment 
and obese or at risk of being obese (BMI > 25 kg/m2) at subsequent time points were defined as 
being exposed, those that did not meet this criteria were defined as being non-exposed  
Covariates 
In addition to assessing whether obesity serves as a predictor of persistent colonization, 
relevant demographic, clinical and behavioral factors were also assessed. Specifically the 
diagnosis of HIV, diabetes and/or hypertension will be controlled for in the final model.  
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Additionally, self-reported age, sex, race (non-Hispanic white, non-Hispanic Black, Hispanic and 
other), antibiotic use in the past six months, Current smoking (yes/no), number of showers per 
week, shared personal items, history of IDU (yes/no) will also be assessed as potential 
confounding factors. 
Statistical analysis 
Means and standard errors were calculated for continuous variables and frequencies and 
percentages were calculated for categorical variables. Bivariate analyses were conducted using 
chi-squared tests and t-tests as appropriate. Multivariable analysis using log-binomial regression 
was then conducted to assess the association between the exposure, obesity, and the likelihood of 
being persistently colonized with S. aureus. Age and gender were included in the model as 
covariates based on a priori knowledge of their association with comorbidity status and persistent 
S. aureus carriage. In addition covariates that were associated with both the exposure and 
outcome with a 20% level of significance and additionally changed the beta estimate for 
comorbidity status by 10% or more were retained in the final model. Statistical interaction by 
gender was assessed by including a product term for obesity and gender in the final model and 
assessing whether the beta coefficient associated with the product term was statistically 
significantly associated with the outcome. Multiple imputation methods were used to impute 
missing covariate data. A total of 20 imputed data sets were generated using the Markov Chain 
Monte Carlo method of imputation to impute missing covariate data. Demographic, behavioral as 
well as self-reported medical data were used to impute missing chart based medical records and 
self-reported drug use behavior. The relative efficiencies of all imputed data exceeded 99%. All 
the imputed data sets were subsequently analyzed to determine whether obesity as defined above 
was significantly associated with persistent S. aureus colonization. 
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A sensitivity analysis was also conducted to evaluate how robust the findings were to 
misclassification of the exposure (obesity). Based on the literature we assumed perfect 
specificity41 and that any misclassification resulted from under reporting of weight and over 
reporting of height. Monte Carlo simulation studies with a uniform distribution and 
bootstrapping methods were then conducted under the assumption that 10% and 15% of the 
population was misclassified, respectively. These individuals were then randomly selected and 
their obesity category changed to what was presumably their “true” obesity category. We 
additionally ran a sensitivity analysis using generalized estimating equations (GEE) as opposed 
to log binomial regression, to evaluate the robustness of our findings given how obesity was 
operationalized.  
To further characterize and distinguish persistent carriers from intermittent carriers we 
calculated the alpha diversity of S. aureus strains among persistent as compared to intermittent 
carriers using Simpson’s Index of Diversity. We additionally took compositional differences 
across the various carriage types into account by performing simple and multiple correspondence 
analyses. Correspondence analysis is a multivariate technique that uses a distance metric to 
extract underlying factors that drive the data distribution. These underlying factors are then used 
to orient the data on a two dimensional plot based on their similarities and dissimilarities.42 The 
principal result of the correspondence analysis is a geometric map or biplot that illustrates how 
the relative frequencies of S. aureus strain types changed with the different carriage types 
(persistent Vs. intermittent) and by carriage type-stratified mucosal site (nares persistent Vs. 
oropharynx persistent Vs. intermittent). To interpret the results, the map origin corresponds to the 
centroid (average) of each variable. The closer a point on the graph is to the origin the closer it is to the 
average observed in the data. Also the closer points are to one another the more similar they are with 
regards to the variables included in the analysis. The spread of the data points from top to bottom and 
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left to right provide an indication of how similar or dissimilar the data are with the center of the 
axis representing the most common characteristics found in the data. All statistical analyses were 
conducted using SAS, version 9.3 (SAS Institute, Inc., Cary, North Carolina). 
RESULTS 
Participation rates at both facilities were high for each phase of the study ranging from 
81-87% for the female prison and 80-94% for the male prison. Characteristics of the total sample 
stratified by S. aureus phenotypic carriage types are presented in Table 4.2. The mean age at 
baseline for study participants was 35 ± 10 years. Approximately 49% of all study participants 
were female, and a little more than two-thirds held a high school diploma or a General Education 
Development test (GED). Forty-four percent of all participants were non-Hispanic black, 26% 
were non-Hispanic white, 24% were Hispanic and approximately 5% were of other or mixed 
race.  
Seventy-four (27%) individuals were persistently colonized in the anterior nares, 
oropharynx or both sites at the species level (Table 4.2). When only the anterior nares were 
considered, 15% of the study participants were persistent carriers, 22% were intermittent carriers 
and 63% were non-carriers. When carriage phenotype assessment was restricted to the 
oropharynx, 17% were persistent carriers, 31% were intermittent and 52% were non-carriers. At 
the strain level 48 (17%) individuals were considered persistent carriers. Approximately 10% of 
participants met the definition of persistent carriage by strain at each mucosal site when assessed 
separately.   
In bivariate analysis, age was the only demographic factor associated or marginally 
associated with S. aureus species and strain persistence. Over 70% of study participants were 
current smokers and smoking was not significantly associated with S. aureus species or strain 
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persistence in bivariate analysis (P> 0.05) (Table 4.2). Though only 12% reported marijuana use 
in the previous six months, 46% had used crack/cocaine in their lifetime 28% had used heroine, 
and 13% had a history of injection drug use. Heroin use appeared to differ across carriage types 
in bivariate analysis with higher usage among intermittent carriers in both species (p value=0.03) 
and strain (p-value=0.08) assessments. None of the medical data appeared to differ significantly 
across S. aureus carriage phenotypes when considering species or strain persistence (Table 4.2). 
Though obesity rates were slightly higher among persistent carriers at the species level (49% vs. 
39%) the association was not significant at the 5% level in bivariate analysis, and prevalence 
rates were essentially the same across carriage phenotypes when strain persistence was 
considered.     
Results of the multivariable model are shown in Table 4.3. In adjusted models, obesity 
was associated with species persistence (Prevalence Ratio (PR)=1.65 95% confidence interval 
(CI)1.09, 2.51) after controlling for age, gender, systemic antibiotic use, diabetes, HIV and 
hypertension. It was, however, not associated with strain persistence (PR=1.37 95% CI 0.78, 
2.46) after controlling for age, gender, systemic antibiotic use, diabetes, HIV, hypertension and 
crack/cocaine use. Younger age was also significantly associated with species persistence (p 
value < 0.05) and marginally associated with strain persistence (p value=0.052). For every one-
year increase in age the prevalence of S. aureus species persistence decreased by approximately 
2.4% (PR=0.97 95% CI 0.95, 0.99).  
Figures 4.1 and 4.2 illustrate the diversity of the 334 different isolates representing 104 
different S. aureus spa types. The most frequent spa type representing 15.4% of all isolates was 
spa type t008. The alpha diversity (Table 4.4) of spa types as assessed by Simpson’s Index of 
Diversity did not significantly differ between persistent (95.3%, 95% CI 93.5%, 97.0%) and 
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intermittent (95.6%, 95% CI 93.3%, 97.8%) carriers. Similar results with wider confidence 
intervals were obtained when persistence was stratified by mucosal site (Table 4.4). When strain 
composition is taken into account using correspondence analysis a different picture is, however, 
painted. Figures 4.3 and 4.4 depict the results of the multiple correspondence analyses assessing 
the distribution of S. aureus strain types by mucosal site and carriage type. Figure 4.3 
demonstrates the biplot when all the different strains isolated are plotted and as is demonstrated 
by the biplot a distinct difference can be observed amongst individuals that are anterior nares 
persistent as compared to all other carriage types. This distinction becomes even more apparent 
when we restrict the analysis to strains that appear in our data set more than once (Figure 4.4). 
We were able to show that certain strains such as t571 seem to be more represented amongst 
individuals that are persistently colonized in the anterior nares, and therefore may favor this 
mucosal environment. We also observed considerable overlap amongst strains colonizing 
intermittent and oropharynx carriers.  
DISCUSSION 
Host and bacterial factors associated with persistent carriage have not been well 
elucidated, particularly in a population such as the incarcerated where S. aureus carriage and 
disease are high, but the opportunity to longitudinally assess carriage patterns are scarce. In the 
current study, S. aureus carriage patterns among NYS maximum-security prison inmates were 
characterized, and the independent effect of obesity on both species and strain persistence of S. 
aureus in the anterior nares and/or oropharynx was assessed. The results demonstrated that 
approximately 27% of the population was persistent carriers at the species level and 17% were 
persistent carriers at the strain level. Obesity was independently associated with species 
persistence but not strain persistence. Diversity of S. aureus strains as assessed by Simpson’s 
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Index of Diversity did not differ between persistent as compared to intermittent carriers. 
Correspondence analysis, however, demonstrated differences in strain composition among 
persistent nasal carriers as compared to all other carriage/mucosal site types.   
We were able to demonstrate a prevalence of S. aureus species persistence similar to 
what has been observed in published literature.14,43 Even when restricting the assessment to 
persistence in the anterior nares our prevalence of approximately 15% remains similar to 
published results in the general population.5 The inclusion of the oropharynx carriage in our 
measure of persistence, however, demonstrates what proportion of individuals would have been 
misclassified as intermittent/non-carriers had this mucosal site not been taken into account. 
Recent studies have shown the importance of ancillary mucosal site on S. aureus disease in the 
absence of nasal carriage.3-5,44 In a study assessing both anterior nares and oropharynx 
colonization, 22% of S. aureus carriage was exclusively nasal as compared to 38%, which were 
exclusively oropharynx.45 Furthermore, 13% of oropharyngeal carriers were considered 
persistent carriers after six years of follow up, and exclusively oropharyngeal and exclusively 
nasal carriers demonstrated genetically distinct clonal clusters. Persistent colonization of the 
oropharynx may partially explain anterior nares decolonization failures in medical settings, as 
well as infections among those that are culture negative at the anterior nares.46 Even more 
interesting are recent findings regarding colonization of the GI tract and its contribution to on 
going disease outbreaks within a clinical setting.5 Expanding our assessment of S. aureus 
persistence to include other mucosal sites would improve our understanding of persistence and 
perhaps introduce some granularity in bacterial factors that might influence S. aureus 
colonization, particularly persistent colonization.  
	
 123
Our study demonstrated a significant association between obesity and persistent S. aureus 
carriage at the species level, but not at the strain level. With regard to S. aureus, obesity has been 
shown to influence both infection and colonization.37,47-49 Obesity is a risk factor for pre-
operative colonization among surgical patients49 as well as colonization among healthy 
community dwelling adults.37,47,48 Among community dwelling adults, a modest association was 
observed between obesity and S. aureus colonization in both men and women using data from 
the National Health and Nutrition Survey (NHANES).47 Their findings were partially 
corroborated by a Norwegian population-based survey16 as well as our group37 where an 
association among women but not men was observed. One postulated mechanism of action is 
that increased adiposity interferes with the immune functionality of the tissue thereby facilitating 
infection and/or colonization.30,50 A recent assessment in mouse models seems to support this 
hypothesis.51 An alternative hypothesis is that obesity may cause chronic-low grade 
inflammation, which is associated with impaired innate and adaptive immune response.30,52 This 
hypothesis is particularly relevant given consistent findings with regards to impaired immune 
function and S. aureus persistent carriage. For example, the activity of antimicrobial peptides 
molecules that bind to proteins and regulate their biological activity in the innate immune 
response is diminished in the nasal secretions of persistent carriers as compared to non-
carriers.19,20,53,54 Other immune related factors that have been shown to be associated with 
persistence include polymorphisms in the glucocorticoid receptor gene,55 single nucleotide 
polymorphisms in the IL4 and C-Reactive protein genes21 as well as lower circulating levels of 
25(OH)D.16 Furthermore, nasal carriage of S. aureus has been described as a “low-grade” 
infectious process that triggers the innate immune response, which if impaired may not be able to 
adequately respond, thereby resulting in persistent colonization.56 Several underlying medical 
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conditions have been shown to affect both the innate and adaptive immune response, including 
obesity.50,57 
We were unable to detect a significant difference in the prevalence of S. aureus strain 
persistence among obese individuals as compared to non-obese. The implementation of this 
definition of persistence was intended to more accurately capture individuals who more closely 
displayed the biological characteristics now frequently associated with persistence including but 
not limited to longer length of time carrying the same strain.9,14 Recent findings do suggest, 
however, that frequent strain replacement does occur even among persistent carriers, however, 
they still generally carry strains for longer periods of time than intermittent carriers.15 Miller et 
al. observed a carriage time of four months or greater among species persistent carriers, however 
12% of their sample carried the same strain for the duration of the study (3 years). Whether 
biological differences (e.g. bacterial load) exist between these long-term strain persistent carriers 
as compared to shorter-term strain persistent carriers remains to be determined. 
In addition to the influence of obesity on persistent carriage, this study also demonstrated 
an independent effect of age on persistent carriage. This finding corroborates published literature 
with regard to younger age and species persistent carriage.17 The mechanism by which 
chronologic age influences persistent carriage has yet to be elucidated. Unfortunately, we were 
unable to see an effect of gender or smoking as has been observed in studies evaluating S. aureus 
persistence.16,18 We additionally did not observe an influence of diabetes, hypertension nor HIV 
on persistent carriage at the species level, however, given the small number of individuals 




 Simpson’s Index of Diversity revealed no significant differences in alpha diversity in 
persistent carriers as compared to intermittent carriers, even when stratified by mucosal site. 
Diversity is a measure of species/strain richness (number of species in a given population) and 
evenness of distribution.58 This simple arithmetic measure of diversity measures the probability 
that two observations taken at random from a population will be of the same type.58,59 Its utility 
has been shown in determining differences in diversity between methicillin susceptible S. aureus 
strains and methicillin resistant S. aureus strains59 as well as differences in S. aureus diversity 
across populations,60 however, it appears to be limited in its ability to differentiate between 
populations with high diversity.59  This limitation is highlighted in our data and underscores the 
importance of taking into account not only diversity but also composition when assessing the 
differences between two populations. Simpson’s Index also does not account for site-specific 
differences when evaluating diversity nor does it reflect the complex relationships that might be 
present in a given habitat. Using correspondence analysis we were able to demonstrate that 
certain strains were over represented among individuals persistently colonized in the nose. We 
were also able to demonstrate a substantial overlap in strains colonizing individuals that were 
persistently colonized in the oropharynx and intermittent carriers.  These observations can help 
inform future hypotheses as to bacterial factors that might delineate affinities for certain mucosal 
sites. Ordination techniques such as correspondence analysis may serve as a good alternative or 
compliment to arithmetic measures of diversity that do not fully account for composition.  
It is important to note that correspondence analysis is an exploratory technique and 
confirmation of these observations; which can be conducted using canonical correspondence 
analysis, the hypothesis driven alternative to multiple correspondence analysis, should be 
addressed in future studies.42 Though correspondence analysis is rarely used in molecular 
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epidemiologic research, it has the potential to bolster molecular analyses for both exploratory 
and hypothesis testing endeavors. We recommend the use of this analytical tool particularly with 
the growing interests in microbial composition at different body sites and their interaction with 
their environment.  
There were several limitations to this study.  First, because of a small sample size there 
was limited power to evaluate factors associated with persistent colonization in this setting and 
therefore only factors with large effects on the outcome and a high prevalence in the setting were 
identified in the analysis. Despite the limited sample size, we were able to show that our 
exposure of interest, obesity, was associated with species persistent carriage, and our sensitivity 
study in which GEE analysis (Appendix Table A4.2) was used to take into account differences in 
covariate values across study visits demonstrated similar results as our primary analysis. Another 
limitation is the self-reported nature of our exposure of interest as well as some of the covariates 
included in the final mode. The outcome of interest however, is persistent colonization, and it is 
unlikely that inmates were aware of their carriage status and therefore any bias is likely non-
dependent and non-differential and therefore attenuated the observed effect given the 
dichotomous nature of our outcome and the majority of our covariates. The quantitative bias 
analysis assessing misclassification of obesity supports these assertions and demonstrated that 
our results were robust to 10% misclassification and marginally robust to 15% misclassification 
(Appendix Table A4.1). Due to limitations in sample size, we were also unable to further stratify 
our exposure category by the presence or absence of markers of metabolic dysfunction, which 
we demonstrated in chapter 3 of this dissertation had an effect on S. aureus colonization. This 
likely attenuated our ability to detect a difference in both species and strain persistence as some 
obese individuals likely presented with no metabolic abnormalities. In addition, the arithmetic 
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measure of genetic composition provides a means of assessing statistical differences in S. aureus 
community structure across carriage types, however it did not take into account differences in 
environment across the different types. We were, therefore, able to determine whether the 
richness and abundance of S. aureus strains differ between the groups but were unable to 
distinguish reasons why. The multivariate analysis using correspondence analysis begins to 
answer this question. However, because it served as an exploratory tool rather than a hypothesis 
driven one, primarily because the chi-squared metric is not tested against an underlying 
distribution, we were unable to draw statistical inferences about the results. Lastly, our measure 
of persistent carriage may have led to some individuals being misclassified as persistent carriers. 
This misclassification would have made the two groups similar and thereby attenuate our ability 
to determine a significant difference in the covariates in our model. We were, however, able to 
demonstrate a significant influence of obesity on persistence, and additionally show that age, a 
factor that has been shown to be associated with persistent carriage was also significant, not only 
at the species, but also the strain level.16 These finding suggest that our definition of persistence 
is likely capturing the underlying biology that differentiates persistent carriers from intermittent 
and non-carriers.   
Despite the limitations listed above, this study had several strengths. First, it is the first 
study to our knowledge to evaluate persistent colonization with S. aureus within the correctional 
setting. This is particularly relevant given the burden of S. aureus colonization and infection 
within the correctional system. Furthermore, few studies have evaluated persistent S. aureus 
colonization in both the anterior nares and the oropharynx outside of health care settings, and this 
study will add to the broader literature trying to identify factors associated with persistent 
colonization. This study was also the first to evaluate both S. aureus genetic composition along 
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with host factors as predictors of persistent carriage in a prison setting. Though we were unable 
to draw inferences from this analysis, it was able to capture subtle differences in community 
structure were identified that could inform future studies that can be empirically tested. Finally, 
we evaluated the influence of obesity on persistent carriage, and show that it may have an 
influence in this setting.      
 In conclusion, the determinants of which phenotypic category of carriage an individual 
demonstrates are still largely unknown. The limited studies that have been conducted in non-
clinical settings demonstrate that the phenomenon is multi-faceted involving environmental, 
genetic, as well as host immune factors. This study suggests that obesity may serve as a host 
factor that may influence persistent carriage, however, due to its small sample size and crude 
measure of persistent carriage based on few points of assessment per observation, corroboration 
is required. Future studies should evaluate the influence of obesity taking not only into account 
anthropometric measures of obesity but also methods that capture the underlying biology that 
places obese individuals at elevated risk of a range of conditions, including infections. The study 
also demonstrates the importance of assessing persistence at other mucosal sites. Approximately 
10% of persistent carriage population would have been missed had we assessed only the anterior 
nares. In assessing the oropharynx the study further demonstrates using multivariate techniques 
that persistent nasal carriage is not only more closely associated with obesity than other types, 




Table 4.1. Different patterns of Staphylococcus aureus Colonization Observed Over Time and the Nomenclature Used to Describe the 
Pattern 
 Time Point 1 
Anterior Nares 
Time Point 1 
Oropharynx 
Time Point 2 
Anterior Nares 
Time Point 2 
Oropharynx 
 
Pattern 1 ✔ ✔ ✔ ✔ Persistent both sites 
Pattern 2 ✔ X ✔ X Anterior nares 
persistent 
Pattern 3 
X ✔ X ✔ Oropharynx 
persistent 
Pattern 4 ✔ X X ✔ Intermittent 
Pattern 5  ✔ ✔ X Intermittent 
Pattern 6 ✔ ✔ X X Intermittent 
Pattern 7 X X ✔ ✔ Intermittent 
Pattern 8 ✔ X X X Intermittent 
Pattern 9 X ✔ X X Intermittent 
Pattern 10 X X ✔ X Intermittent 
Pattern 11 X X X ✔ Intermittent 
Pattern 12 X X X X Non carrier 
X    = No isolate identified 





Table 4.2. Baseline Demographic, Behavioral and Medical Characteristics of New York State Maximum-Security Inmates Stratified 
by Carriage Phenotype of Staphylococcus aureus at the species and strain level, 2009-2014  












N=226 (82.5) P Value 
DEMOGRAPHICS             
Age mean age ± SD 34.2 ± 10.5 36.6 ± 10.1 0.0836 33.1 ± 9.6 36.6 ± 10.3 0.03 
Female Gender 36 (48.7) 97 (48.5) 0.9826 21 (43.8) 112 (49.6) 0.46 
Race             
Non-Hispanic White 19 (25.7) 52/198 (26.8) 0.715 11 (22.9) 61/224 (27.2) 0.92 
Non-Hispanic Black 33 (44.6) 89/198 (45.0)   23 (47.9) 99/224 (44.2)   
Hispanic 20 (27.0) 45/198 (22.7)   12 (25.0) 53/224 (23.7)   
Otherb 2 (2.7) 11/198 (5.6)   2 (4.2) 11/224 (4.9)   
Education     0.8635     0.70 
< High school 21 (28.4) 61 (30.5)   16 (33.3) 66 (29.2)   
High School/Equivalent 30 (405) 74 (37.0)   19 (39.6) 85 (37.6)   
> High school 23 (31.1) 65 (32.5)   13 (27.1) 75 (33.2)   
BEHAVIOR             
Smoking 56 (75.7) 142 (71.0) 0.4427 35 (72.9) 163 (72.1) 0.91 
Marijuana Use in Past 6 Months 11/73 (15.1) 20/198 (10.1) 0.2544 11/73 (15.1) 20/198 (10.1) 0.25 
Crack/Cocaine Use Ever 29/72 (40.3) 98/199 (49.3) 0.1913 29 (40.3) 98 (49.3) 0.19 
Heroin Use Ever 13 (17.6) 60 (30.0) 0.0388 8 (16.7) 65 (28.7) 0.08 
History of Injection Drug Use 8/71 (11.3) 28 (14.4) 0.5144 5/45 (11.1) 31/221 (14.0) 0.60 
Shares Personal Items 18 (15.8) 18 (11.3) 0.2729 5 (10.4) 31 (13.7) 0.54 
< 7 Showers per Week   22 (29.7) 66 (33.0) 0.6067 13 (27.1) 75 (33.2) 0.41 
Mean Time Between 1st and 2nd  
Interview (mean ± SD) 256 ± 239.9 298 ± 275.0 0.2577 182 ± 172.2 309 ± 277.4 0.00 




Diabetes 7 (9.5) 14 (7.0) 0.4968 4 (8.3) 17 (7.5) 0.85 
Hypertension 9/70 (12.9) 27/189 (14.3) 0.7679 6 (13.3) 30 (14.0) 0.90 
HIV  2 (2.7) 13 (6.5) 0.2199 2 (4.2) 13 (5.8) 0.66 
Liver Disease 8 (10.8) 37 (18.5) 0.1272 5 (10.4) 40 (17.7) 0.21 
Kidney Disease  2 (2.7) 8 (4.0) 0.611 2 (4.2) 8 (3.5) 0.83 
Systemic Antibiotic Use in Past 6 
Months 31 (41.9) 67 (33.5) 0.1982 17 (35.4) 81 (35.8) 0.96 
Topical Antibiotic Use in Past 6 
Months 16 (21.6) 36/198 (18.2) 0.5209 11 (22.9) 41/224 (18.3) 0.46 
Exposure of Interest             
Obese (BMI ≥ 30 kg/m2) 36 (48.7) 78 (39.0) 0.1502 20 (41.7) 94 (41.6) 0.99 
Definitions: obese BMI ≥ 30.0 kg/m2; HIV, Human Immunodeficiency Virus 
aPersistent carriage is defined by colonization of the anterior nares and/or oropharynx with Staphylococcus aureus at all time points 
assessed 






Table 4.3. Multivariable Model Assessing the Independent Effect of Being Obese On Staphylococcus aureus Species and Strain 
Persistent Carriage among New York State Maximum-Security Inmates 










BMI < 30kg/m2 Ref Ref Ref Ref 
BMI >= 30 kg/m2 1.33 (0.90, 1.96) 1.54 (1.01, 2.38) 1.00 (0.59, 1.68) 1.15 (0.60, 2.05) 
AControlling for age at baseline, gender, antibiotic use in the past six months, diabetes, hypertension and HIV 
BControlling for age at baseline, gender, antibiotic use in the past six months, diabetes, hypertension, HIV and crack/cocaine use 
Persistent carriage is defined by colonization of the anterior nares and/or oropharynx with Staphylococcus aureus at all time points 
assessed 
Species persistence is defined by colonization with any Staphylococcus aureus strain at all time points assessed 
Strain persistence is defined by colonization with the same Staphylococcus aureus strain at all time points assessed 






Figure 4.1. Relative Abundance of the Fifty most Frequently Isolated Staphylococcus aureus Spa Types Isolated From New York 
State Maximum Security Inmates by Carriage Type  
 




Figure 4.2. Relative Abundance of the Fifteen most Frequently Isolated Staphylococcus aureus Spa Types From New York State 
Maximum Security Inmates by Carriage Type  
 
Figure 4.2. Illustrates the relative abundance of Staphylococcus aureus spa types isolated five or more times among participants 




Table 4.4. Alpha Diversity of Staphylococcus aureus Strains Stratified by Persistent Carriage Defined Globally and by Mucosal Site 
  
Simpson's Diversity 
Index 95% CIb 
Global Persistencea 
Persistent 95.25% (93.49, 97.02) 
Intermittent 95.56% (93.3, 97.76) 
Persistence by Mucosal Site 
Colonized at Both Sites Persistently 92.35% (88.15, 96.55) 
Anterior nares Persistent 94.43% (91.51, 97.34) 
Oropharynx Persistent 93.54% (89.86, 97.20) 
Intermittent 95.56% (93.37, 97.76) 
aGlobal Persistence refers to individuals colonized with Staphylococcus aureus at the same mucosal site (anterior nares or oropharynx) 
at every point of assessment time 









Figure 2.  Geometric biplots from a multi-way correspondence analysis assessing the distribution of spa clonal complex across levels 
of carriage type. The figure demonstrates that persistent nasal colonization is slightly different than other carriage types with regards 















Figure 4.  Geometric biplots from multi-way correspondence analysis assessing the distribution of spa types across levels of carriage 
type.  Dimension 1 corresponds to the most important underlying factor driving the distribution of the data points and dimension 2 
corresponds to the second most important factor. The asterisks correspond to where specific spa types fall with respect to the 
dimensions extracted and how they relate to the carriage type. To interpret the results, the broad direction of spread of the points from 
top to bottom and left to right provide an indication of how similar or dissimilar the data points are with the center of the axis, which 
represents the most common characteristics found in the data. The results suggest that individuals that are colonized in the nose are 
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Appendix 4  
Table A4.1. Sensitivity Analysis Assessing the Influence of Misclassification of Body Mass 
Index Category on the Association between Obesity and Persistent Staphylococcus aureus 
Carriage 
Characteristic Observed 10% Misclassificationa 15% Misclassificationa 
 Species Persistentb Species Persistentb Species Persistentb 
 Adjusted PR (95%CI) Adjusted PR (95%CI) Adjusted PR (95%CI) 
BMI < 30kg/m2 Ref Ref Ref 
BMI >= 30 kg/m2 1.54 (1.01, 2.38) 1.44 (1.01,1.89) 1.42 (0.99, 1.84) 
Total sample size for misclassification assessment was 263/274, due to missing covariate data 
aControlling for age at baseline, gender, antibiotic use, diabetes, hypertension and  HIV 
Persistent carriage is defined by colonization of the anterior nares and/or oropharynx with 
Staphylococcus aureus at all time points assessed 
bSpecies persistence is defined by colonization with any Staphylococcus aureus strain at all time 
points assessed 





Table A4.2 Sensitivity Analysis Using Generalized Estimating Equations to Account for 
Differences in Observed characteristics Across Visits.  











30kg/m2 Ref Ref Ref Ref 
BMI >= 30 
kg/m2 1.33 (0.90, 1.96) 1.59 (1.10, 2.31) 1.10 (0.61, 1.76) 1.38 (0.83, 2.30)
Definitions: obese BMI ≥ 30.0 kg/m2; HIV, Human Immunodeficiency Virus 
aControlling for age at baseline, gender,  antibiotic use, diabetes, hypertension and HIV 














N=2,829 P Value 
DEMOGRAPHICS       
Age mean age ± SD 35.9 ±10.2 36.6 ± 10.6 0.3529 
Female Gender 133 (48.5) 1,357 (47.9) 0.8562 
Race       
Non-Hispanic White 72 (26.3) 603 (21.3) 0.1911 
Non-Hispanic Black 122 (44.5) 1,408 (49.8)   
Hispanic 66 (24.1) 647 (22.9)   
Othera 14 (5.1) 171 (6.0)   
Education     0.6733 
< High school 82 (29.9) 914 (32.3)   
High School/Equivalent 104 (38.0) 1,064 (37.6))   
> High school 88 (32.1) 851 (30.1)   
BEHAVIOR       
Smoking 181/273 (66.3) 1,840 (65.0) 0.6766 
Marijuana Use in Past 6 
Months 31/274 (11.4) 313/2,813 (11.1) 0.8761 
Crack/Cocaine Use Ever 107/268 (39.9) 1,061 (37.6) 0.4605 
Heroin Use Ever 63/272 (23.2) 461/2,821 (16.3) 0.0042 
History of Injection Drug Use 30/265 ((11.3) 252/2,799 (9.0) 0.2123 
MEDICAL       
BMI mean ± SD 28.5 ± 5.2) 28.6 ±5.6) 0.7485 
Diabetes 21/268 (7.8) 188 (6.6) 0.4578 
Hypertension 46/68 (17.2) 511 (18.1) 0.7142 
HIV  14/268 (86) 115 (4.1) 0.3641 




Kidney Disease  10/268 (3.7) 59 (2.1) 0.081 
Systemic antibiotic use 98 (35.8) 870/2,818 (30.9) 0.0954 
Topical antibiotic use 52 (19.1) 468 (16.7) 0.3029 
Outcome of Interest       
Colonized 132 (48.2) 1,334 (47.2) 0.7466 
Definitions: obese BMI ≥ 30.0 kg/m2; HIV, Human Immunodeficiency Virus 




CHAPTER 5: Conclusions 
Despite its ability to cause invasive disease such as necrotizing pneumonia,1 at any given 
time Staphylococcus aureus is most commonly a commensal and comprises part of the resident 
flora of the human anterior nares in 25-30% of individuals worldwide.2 In the majority of these 
individuals S. aureus colonizes their anterior nares persistently, whereas the remainders are only 
intermittently colonized.2,3 Individuals colonized with S. aureus are at elevated risk of infection. 
In fact, in clinical settings, approximately 80% of S. aureus infections have been attributed to the 
endogenous colonizing strain,4 and persistently colonized individuals appear to be at elevated 
risk.5 Factors that influence S. aureus colonization are thought to be multifactorial and are host, 
bacterial as well as environmentally determined. Host determinants of S. aureus carriage include 
demographic (younger age, male sex),6 behavioral (smoking,6 injection drug use,7,8 contraception 
use9), host environment (previous exposure to health care settings), genetic (genetic 
polymorphisms in genes that code for interleukin-4 (IL-4),10 C-reactive protein (CRP), 10 and β-
defensin 111), immunological (antimicrobial peptide secretion,12,13 and serum 
25hyrdroxyvitaminD levels6)   as well as host pathology (obesity,14-16 HIV,7 diabetes16-18). 
Unfortunately, the mechanisms by which many of these factors influence carriage are still poorly 
understood, and factors that determine carriage type (persistent vs. Intermittent) are still largely 
unknown. Despite these uncertainties, studies have consistently implicated both the innate and 
adaptive immune response in S. aureus carriage, and are thought to be a significant host 
determinant of colonization.19  
Interestingly, many of the innate and adaptive immune factors that have been shown to 
influence S. aureus colonization are also impacted in obesity.20-22 For example, circulating levels 
of 25(OH)D, which has a significant influence on the immune response,22 are decreased among 
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obese individuals.21 Similarly, IL-4, a cytokine whose levels are generally associated with an 
anti-inflammatory immune profile,23 levels are also decreased in obese individuals.24 
Furthermore, obesity has been shown to influence S. aureus colonization,14-16 however, the 
mechanism by which it elevates risk remains elusive and its influence on persistent S. aureus 
colonization, prior to this dissertation work, had yet to be evaluated. Among studies that have 
assessed the influence of obesity on S. aureus colonization, two pervading hypothesis have 
emerged. The first postulated mechanism of action suggests that the expansion of adipocytes due 
to obesity decreases the immune functionality of the tissue thereby facilitating infection and/or 
colonization.25,26 An alternative hypothesis is that obesity may cause chronic-low grade 
inflammation, which is associated with a systemic impaired immune response.26,27 These 
hypotheses are not mutually exclusive, and may be working in tandem to influence colonization. 
This dissertation begins to address the question of mechanism by addressing fundamental issues 
of measurement that may limit not only our ability to detect an association between obesity and 
S. aureus colonization, be it intermittent or persistent, but also our ability to differentiate among 
hypotheses about the mechanism by which it acts. It does so by not only recognizing the 
importance of granularity in our measurement of obesity, as has been advocated by many,28 but 
also granularity in our measurement of colonization, particularly persistent colonization.29  
Guided by a conceptual framework that interwove the effects of metabolic abnormalities 
and immune dysfunction frequently observed in the presence of obesity, this dissertation had two 
primary goals. The first was to determine whether sub-phenotypes of obesity based on body 
mass index (BMI) category and metabolic abnormalities would begin to elucidate the 
mechanisms by which obesity influence S. aureus colonization. The second goal was determine 
qualitatively whether a pronounced association would be observed between obesity and 
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persistent S. aureus carriage, a characteristic defined primarily by a compromised innate and/or 
adaptive immune response. These goals were accomplished by first conducting a systematic 
review to evaluating whether the chosen measure of persistent carriage affected the yield of 
persistent carriers in a sample population. We then used regression methods to isolate the effects 
of body mass index (BMI) category (normal weight, overweight, obese) stratified by metabolic 
health status on S. aureus colonization (inclusive of both intermittent and persistent carriers) in 
two maximum-security prisons in New York State. We then integrated our findings in Chapter 
one of this dissertation to our understanding of persistent carriage and defined persistence at both 
the species as well as the strain level, hypothesizing that the two measures were capturing 
distinct yet overlapping subpopulations of persistent carriers. Regression and multivariate 
ordination techniques were then used to evaluate the impact of obesity on S. aureus carriage type 
(persistent Vs intermittent) as well as explore any difference in S. aureus strain composition that 
may exist between persistent and intermittent carriers.    
  
Summary of Study Findings 
 To better understand how to evaluate the influence of obesity on colonization (inclusive 
of both persistent and intermittent carriers) and persistent carriage exclusively, we first sought to 
determine whether a specific measure of persistent carriage captured the underlying biological 
characteristic better than others. To do this we conducted a systematic review to identify studies 
that evaluated persistent S. aureus carriage in non-institutionalized adults. The primary aim of 
the review was to assess the different methods used to measure persistent S. aureus carriage, and 
to determine whether variation in the measure affected the prevalence of persistent carriage 
observed. Chapter two of this dissertation summarized the results of the review. In short, the 
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review resulted in 19 articles that demonstrated considerable variation in how persistent S. 
aureus colonization was measured in non-institutionalized settings.  The various definitions were 
collapsed into four general categories: culture positivity on all samples taken a minimum of one 
week and a maximum of a few months from one another,11,29,30 two positive cultures taken 
approximately one week apart (culture rule31),6,9,10,32-37 two positive cultures taken several 
months and sometimes a few years apart38-42 and lastly culture positivity in at least 80% of all 
cultures taken7,31 (carrier index rule43). Despite the variation in the definitions used, the 
prevalence of persistent carriage ranged from 16-34%. Even more interesting was the 
consistency in the range of persistent carriage estimates reported across the broad categories 
identified. A summary estimate of 11 of the 19 studies (excluding redundant studies and studies 
with a high risk of bias) resulted in an estimated prevalence of persistent carriage of 22% (95% 
CI 19%-25%). The results of the systematic review suggests that identifying persistent carriers 
may be relatively robust to the definition used, and having at least two swabs may be sufficient 
to differentiate persistent carriers from intermittent carriers. More importantly, the review 
suggested that two sup-populations of persistent carriers may exist and evaluating species 
persistence casts a wide net that captures all individuals carrying S. aureus consistently, whereas 
strain persistence restricts our assessment to those who may be particularly long term carriers of 
a given strain.  
 The third chapter evaluated whether BMI category (normal weight vs. overweight vs. 
obese) further stratified by presence and absence of comorbidities (diabetes, hypertension and 
HIV) was associated with S. aureus carriage, inclusive of both intermittent and persistent 
carriers. The primary hypothesis of this study was that abnormal metabolic health, defined by the 
presence of comorbidities, was partially driving the association between obesity and S. aureus 
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that we14 and others15,16 have described. Interestingly, our findings mirrored what has been 
described in the literature with regards to the sub-phenotypes of obesity and metabolic disease44 
in that normal weight individuals with metabolic abnormalities (MANW) had a higher likelihood 
of colonization than obese individuals without metabolic abnormalities. More specifically, the 
study demonstrated that MANW females had a significantly higher prevalence of S. aureus 
colonization than metabolically healthy normal weight (MHNW) females. A slightly lower but 
still significant increase in S. aureus prevalence was also observed among metabolically 
abnormal obese (MAO) females as compared to MHNW females. No association was observed 
among overweight females with or without markers of metabolic abnormalities or among 
metabolically healthy obese (MHO) females. Though the results partially supported our 
hypothesis, the negative finding among MHO females was surprising, given the reported 
association independent of diabetes14-16 and pre-diabetes.15 These studies, however, could have 
been further refined to control for hypertension, which may be interacting with other factors to 
elevate risk. It is also important to note that when the influence of metabolic abnormal health 
was evaluated by BMI category we observed a significant increase in prevalence in MANW 
females as compared to MHNW females, but did not observe a significant difference in MAO 
females as compared to MHO females. This suggests that though not statistically significant, the 
prevalence of S. aureus in MHO as compared to MHNW is likely not negligible. Other factors 
may, therefore, also be at play that place obese individuals at elevated risk of colonization. No 
association between normal weight, overweight, or obese males with or without markers of 
metabolic abnormalities and the prevalence of S. aureus colonization was observed.  
A secondary aim addressed in the third chapter was the impact of the sub-phenotypes of 
obesity on site of colonization. We hypothesized that increasing comorbidity would result in 
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significant increase in exclusive anterior nares colonization. This analysis was based on 
preliminary results suggesting that anterior nares colonization was driving the observed 
association between obesity and the prevalence of S. aureus colonization among females.14 The 
findings among female participants did not support our hypothesis; however, we did observe a 
marginally significant increase in exclusive anterior nares colonization among obese male 
inmates with metabolic abnormalities as compared to normal weight males with no metabolic 
abnormalities. The results of both the primary and secondary aims addressed in chapter three 
suggest that metabolic abnormalities might be driving the observed association between obesity 
and the prevalence of S. aureus colonization. More importantly, they suggest that sub-
phenotypes of obesity might refine our ability to capture the underlying biological processes that 
are more prevalent among obese individuals and presumably drive its association with a 
multitude of conditions.   
After determining the influence sub-phenotypes of obesity on S. aureus colonization, 
inclusive of both intermittent and persistent carriers, we then evaluated the influence of obesity 
on persistent carriage in the fourth chapter. This analysis was conducted to further characterize 
the association between obesity and the prevalence S. aureus colonization and the extent to 
which obese individuals are at risk. The results of our systematic review served as reassurance 
that two samples would perform well in capturing persistence.  We attempted to assess 
persistence not only at the species levels, but also at the strain level under the assumption that the 
two measures were capturing slightly different but overlapping groups of persistent carriers. 
Under the guidance of the framework, we hypothesized that obese individuals would be at 
elevated risk of persistent carriage in either the anterior nares and/or oropharynx. The results 
demonstrated that approximately 27% of the population were persistent carriers at the species 
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level and 17% were persistent carriers at the strain level. Had our assessment been restricted to 
the anterior nares, 10% of individuals that were persistently colonizes in the oropharynx would 
have been misclassified as intermittent/non-carriers. Obesity was independently associated with 
species persistence but not strain persistence.  
The fourth chapter additionally addressed the distribution of S. aureus strains as 
differentiated by spa typing across carriage types. Specifically, carriage patterns were further 
characterized by evaluating the molecular characteristics of the colonizing strains using two 
different methods. The first method, Simpsons Index of Diversity focused primarily on richness 
(i.e. number of different strains represented in the sample), whereas the second method, 
correspondence analysis, focused primarily on composition. Diversity of S. aureus strains as 
assessed by Simpson’s Index did not differ among persistent as compared to intermittent carriers. 
When carriage was further stratified by site of colonization (nares persistent, oropharynx 
persistent, intermittent), the differences remained null. Correspondence analysis, however, 
demonstrated differences in strain composition among persistent nares carriers as compared to all 
other carriage/mucosal site types. The assessment also demonstrated that when restricted to 
strains that appear at least twice in the data set, persistent oropharynx carriers were similar to 
intermittent carriers at any mucosal site. Given the a priori exploratory nature of the 
correspondence analysis as a hypothesis-generating tool, future studies need to confirm findings, 
but the overall results suggest that correspondence analysis might be better suited to evaluate 
compositional differences in sub-populations with highly diverse strains.  
 
Implications and Future Directions  
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The results of this study suggest that metabolic abnormalities, which are more prevalent 
in obese individuals, may partially account for the association observed between obesity and S. 
aureus carriage. The association appears to get stronger when persistent carriage is assessed, and 
may have differential effect on the different epithelial sites frequently assessed for S. aureus 
colonization. The overall study results have implications regarding how obesity is measured and 
operationalized in infectious disease research, the importance of addressing different mucosal 
sites, the importance of molecular biology in our assessments, and lastly to the extant literature 
evaluating sub-phenotypes of obesity  
Individual and Public Health Implications 
First and foremost, the study suggests that MANW and MAO individuals, particularly 
females, are at elevated risk of S. aureus colonization, thereby by placing them at risk of 
infection by the organism. The public health impact on MAO individuals, however, will be more 
pronounced.  The above observation is due to the fact that only a moderate relative increase in 
carriage prevalence was observed for both MANW and MAO individuals, however, the relative 
prevalence of the two phenotypes are very different. Current estimates suggest that 1.9 billion 
adults worldwide are overweight and over 600 million are obese.45 In the United States, over 
30% of adults 20 years of age or older are obese, and rates are higher among Hispanics (42%) 
and non-Hispanic Blacks (48%).46 The prevalence of MAO among all individuals defined as 
obese, primarily based on BMI, ranges from 51-70%.47,48 Given the absolute number of 
individuals who are obese or at risk of being obese and the relative prevalence of MAO among 
obese individuals, a substantial number of individuals are therefore at risk of carriage and 
therefore subsequent infection. In contrast, only 23%48 of normal weight adults are considered 
MANW and rates as low as 7% have been reported. Should the study findings be validated in 
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another population, the relative prevalence of the different sup-phenotypes should be taken into 
account if any public health interventions are subsequently assessed.  
The relative increase in S. aureus carriage among MANW and MHO individuals 
demonstrated by the study results may also have global implications for the microbial 
composition of epithelial surfaces in these individuals. Epithelial surfaces form the interface 
between the host and its exterior environment, and are therefore the main route of entry for 
microbial organisms.49 Important changes in epithelial tissue have been observed amongst obese 
individuals, and the microbial composition at these sites has been shown to differ between obese 
and non-obese individuals.50-52 Composition has also been used to distinguish individuals with 
impaired glucose control from those with no impairment,53 providing further evidence of 
compositional differences at epithelial sites in the presence and absence of disease. Though this 
evidence for microbial compositional changes in the presence of obesity have focused primarily 
on the gut microbiome, studies are accumulating that suggest compositional shifts observed in 
one epithelial surface might be reflective of compositional shifts in other areas. Specifically, 
Zhang et al. observed that dysbiosis in gut microbial composition in the presence of rheumatoid 
arthritis was reflected in the oral and saliva microbiome as well.54 Furthermore, host genetic 
variation, which has limited effects on the microbiome as compared to diet, the environment and 
disease, does influence microbial composition across different body sites55 lending credence to 
the hypothesis that dysbiosis at one site could be an indicator of dysbiosis at other sites. More 
specific to our topic and the implications therein is the idea that the dysbiosis we observe in gut 
microbiota in obesity may be an indication of shifts in the microbiome of other epithelial 
surfaces such as the anterior nares and/or oropharynx making those surfaces more susceptible to 
S. aureus colonization as well as other opportunistic pathogens. This hypothesis is supported by 
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the fact that studies assessing S. aureus colonization within the context of the entire microbial 
composition of the anterior nares have linked distinct phylotypes to the presence or absence of 
the organism.56 Future studies should include assessments of the entire microbiome of the 
epithelial sites being assessed.  
Research Implications 
In addition to the individual and public health implications of these findings are those 
relevant to how obesity is evaluated in research settings, and the most salient to this particular 
study is its operationalization in studies related to infectious outcomes. The biology of obesity is 
complex and displays a heterogeneous effect on health. The methods used to measure obesity 
may account for the variability, as each measure makes an implicit assumption about the 
distribution or composition of adipose tissue that may not be consistently met. For example, BMI 
makes an implicit assumption of even distribution of adipose tissue. However, research 
demonstrates that body fat distribution varies at the minimum by sex and age.57 Though the use 
of BMI to report secular trends in obesity is likely appropriate, its use to estimate the effects of 
obesity on different disease states might be flawed due to its imprecision in capturing the 
biological processes driving the disease.58 Studies assessing the influence of obesity on 
metabolic complications take these factors into account, however to date, no study assessing the 
influence of obesity on susceptibility to infectious organisms has addressed the limitations of 
BMI. Understanding the heterogeneity associated with each measure of obesity as it relates to the 
host’s susceptibility to infectious organisms might elucidate some of the mechanisms driving the 
relationships.  
Our study provides proof of concept that sub-phenotyping obesity might be relevant in its 
assessment of infectious disease outcomes. Future studies assessing obesity and infectious 
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outcomes should implement a method of sub-phenotyping to not only provide support for the 
underlying biological framework, but to add a degree of granularity so that small but important 
associations are not overlooked. Even more important, but much more costly would be the 
incorporation of methods that measure body composition59 in an attempt to fully describe the 
differences observed in this and other studies14,15 between males and females with regards to 
excess adiposity and carriage.  
Another methodological implication highlighted by these results is the importance of not 
only considering species/strain richness but also composition when evaluating molecular biology 
as it relates to specific outcomes. Diversity is a measure of species/strain richness (number of 
species in a given population) and evenness of distribution.60 Many studies use simple arithmetic 
measures of diversity such as Simpson’s Index, which measures the probability that two 
observations taken at random from a population will be of the same type, to evaluate strain 
diversity within a given population.60-62 Simpson’s Index is easily calculated and is the most 
frequently used arithmetic indices of diversity. Unfortunately, like other arithmetic diversity 
indices, it does not take into account site-specific differences when evaluating diversity nor does 
it reflects the complex relationships present in a given habitat. Multivariate ordination techniques 
such as correspondence analysis have the flexibility to take into account these complexities.63 
These techniques have been used to evaluate species/strain composition in the field of ecology 
for some time, and are only now being implemented in microbiology to evaluate strain 
composition.64-66 The goal of correspondence analysis, as well as other ordination techniques, is 
not to test a hypothesis about the data structure, but to merely describe the data structure more 
concisely. Correspondence analysis was able to show genetic compositional differences across 
carriage types (i.e. anterior nares persistent vs. oropharynx persistent vs. Intermittent), where 
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Simpson’s Index of Diversity was not able to detect differences in strain diversity by carriage 
type.  
 The final research implication is in how persistent S. aureus carriage is defined. With 
respect to this issue two salient points need to be addressed. The first point relates to the relative 
benefit of assessing strain persistence as compared to species persistence. In her comprehensive 
study evaluating the acquisition and loss of S. aureus carriage over a three-year period, Miller et 
al. questioned the existence of a truly persistent carriage type.29 The primary reasoning behind 
their conclusion, despite the 12% of individuals that carried the same strain throughout the three-
year period, was the consistent and linear rate of carriage loss observed throughout the study. A 
recent study challenged their conclusion suggesting that strain replacement is not uncommon 
even among persistent carriers; however, the length of time in which strains are carried is 
significantly longer in persistent carriers as compared to intermittent carriers.67 This and many 
other factors make them distinctly different from individuals described as intermittent carriers. 
The level of granularity used to measure persistence, we argue is likely dependent on the 
question being assessed. If the goal is to identify individuals at risk of infection, then casting a 
wide net to include individuals who are consistently colonized, i.e. primarily colonized due to 
frequent exposure or other biological factors, as well as “true” persistent carriers, i.e. individuals 
that demonstrate higher bacterial loads and longer carriage times, is warranted. In this instance 
species persistence may suffice. If, however, the research aim is to determine factors associated 
with the biological characteristics of persistent carriage, then granularity in the measure such as 
refining the definition of persistence to at the strain level, may be warranted. However, the need 
to restrict the definition to capture individuals carrying the same strain indefinitely may overlook 
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important differences that have already been described between long time carriers at the species 
level and intermittent carriers.  
 The second issue that requires attention is the need for more studies evaluating S. aureus 
persistent carriage at other mucosal sights. By including an oropharyngeal assessment we were 
able to not only increase our detected prevalence of persistence, but also show that compositional 
differences may exist in strains that colonize persistent nasal carriers as compared to 
oropharyngeal carriers. Only one other study was identified that evaluated persistence in the 
oropharynx in non-clinical settings. However, direct comparison with our findings was hindered 
due to the inclusion of children, whose epidemiology of S. aurues differs substantially from that 
of adults, in their sample population.68  
Broader Implications of study findings  
The study findings also have broader implications with regard to controversies 
surrounding the practice of using sub-phenotypes of obesity to assess health outcomes. Critics of 
the use of sub-phenotypes argue that a lack of consensus in how the sub-phenotypes, particularly 
MHO, are defined hinders comparison of results across studies.69 For example a study 
implementing three definitions of MHO reported an observed prevalence ranging from 8.5% to 
44% across the definitions.70 In addition, inconsistencies in study findings, particularly with 
regards to the association between MHO with all-cause mortality, have been observed across the 
numerous definitions.71-73 Our study adds to this complexity, in that we were unable to utilize 
established measures of metabolic health, but relied on the diagnosis of metabolic diseases to 
capture the biological processes of interest. In doing so we likely captured individuals on the tail 
end of what is likely a spectrum of risk rather than identifying MHO as a benign condition as 
implied by the designations. Never the less, we were able to show that introducing these sub-
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phenotypes offered new insights for our infectious outcome. We also provide support for the 
argument74 that, though imperfect, these sub-phenotypes not only highlight the physiological 
differences represented in what we view as homogenous condition, but that these differences 
have a measurable influence on health outcomes.  
The fluidity in the concept of MHO is another aspect of the controversy that warrants 
mention and plays a significant role within the context of infectious outcomes. We use fluidity 
here to describe the mounting evidence suggesting the transiency of the MHO phenotype.75,76 
Indeed, in long term follow up studies, a large proportion of individuals described as MHO at 
baseline transition to MAO and eventually demonstrate similar health outcomes as those 
described as MAO from baseline.75,76 The fluidity is particularly pronounced among young 
adults and appears to become more stable in older adults.75 Critics have used this fluidity when 
MHO is assessed in the long term to argue against its use.69 It is important to emphasize, 
however, that short term differences have been observed.75 More importantly, in the case of 
infectious outcomes, particularly acute infections/outcomes where the short term risks are of 
specific interest, factors that add a degree of granularity in our measures may improve our ability 
to detect subtle differences that would otherwise be overlooked. In addition, interventions to 
prevent MHO individuals from becoming MAO may be of substantial utility.  
A parallel debate in which these results play into is the concept of cardio respiratory 
fitness (CRF) as compared to fatness and health outcomes. Advocates of the fitness hypothesis 
argue that CRF is more important in determining poor health outcomes such as heart failure77 
than fatness as defined by BMI. Even when fitness is assessed within categories of obesity sub-
phenotypes, an effect of fitness is observed.78 The concept of fitness provides an even more 
nuanced view of adiposity and sheds further light on the degree of heterogeneity encompassed in 
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what is traditional viewed as a benign concept (i.e. obese vs. not obese). Whether additionally 
assessing fitness would further improve research on health outcomes as they relate to infectious 
disease remains to be determined, and warrants investigation.  
In conclusion, the epidemiology of obesity is evolving. Though traditionally considered a 
risk factor for metabolic conditions such as insulin resistance and chronic disease, evidence now 
also indicates that obesity increases vulnerability to colonization and infection by infectious 
organisms such as S. aureus.15,16 Inconsistencies, however, with regard to S. aureus as well as 
other infectious organisms have been observed. Reconciling these inconsistencies would provide 
the field with a clearer path forward, and one way to reconcile the inconsistencies is to introduce 
a degree of granularity in our measures of obesity. Sub-phenotypes of obesity could introduce 
the necessary granularity, and should therefore be incorporated in research assessing obesity and 
infections. We provide a proof of concept with this dissertation, and also discuss several factors 
that need to be taken into account in future work. Given the growing prevalence of obesity and 
the increasing evidence suggestive of its interaction with both the benign and opportunistic 
pathogens that comprise the micro flora of different human mucosal sites, understanding how 
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